Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	transcription factor binding	CEBPG PPRC1 FOS PCLO ID2 TACC2 MED1 HNRNPU CCNT2 TAF3 PER2 NFE2L2 NCOA1 HSPA4 TP53BP1 TP53BP2 DNMT1	6.22e-05	753	152	17	GO:0008134
GeneOntologyMolecularFunction	chromatin binding	TICRR TSHZ3 RNF169 SMARCA5 ZNF609 FOS MED1 FANCM SARNP HNRNPU CCNT2 GLI3 NCOA1 ASXL2 TOP1 DNMT1	1.67e-04	739	152	16	GO:0003682
HumanPheno	Accessory oral frenulum	KIAA0586 EFTUD2 SCNM1 GLI3	1.87e-05	19	45	4	HP:0000191
HumanPheno	Hypochloremia	CLCNKA CLCNKB MAGED2	2.20e-05	7	45	3	HP:0003113
Domain	Cl_channel-K	CLCNKA CLCNKB	6.67e-05	2	153	2	IPR002250
Domain	TACC	TACC2 TACC3	1.99e-04	3	153	2	PF05010
Domain	ALMS_motif	ALMS1 CEP295	1.99e-04	3	153	2	IPR029299
Domain	ALMS_motif	ALMS1 CEP295	1.99e-04	3	153	2	PF15309
Domain	TACC	TACC2 TACC3	1.99e-04	3	153	2	IPR007707
Domain	CBS	IMPDH2 CLCNKA CLCNKB	2.79e-04	16	153	3	SM00116
Domain	DENN	DENND1A DENND4C SBF2	2.79e-04	16	153	3	SM00799
Domain	DENN	DENND1A DENND4C SBF2	2.79e-04	16	153	3	PF02141
Domain	dDENN	DENND1A DENND4C SBF2	2.79e-04	16	153	3	PF03455
Domain	UDENN	DENND1A DENND4C SBF2	2.79e-04	16	153	3	PS50946
Domain	DDENN	DENND1A DENND4C SBF2	2.79e-04	16	153	3	PS50947
Domain	dDENN	DENND1A DENND4C SBF2	2.79e-04	16	153	3	SM00801
Domain	dDENN_dom	DENND1A DENND4C SBF2	2.79e-04	16	153	3	IPR005112
Domain	uDENN_dom	DENND1A DENND4C SBF2	2.79e-04	16	153	3	IPR005113
Domain	DENN	DENND1A DENND4C SBF2	2.79e-04	16	153	3	PS50211
Domain	DENN_dom	DENND1A DENND4C SBF2	2.79e-04	16	153	3	IPR001194
Domain	-	GAS2 MICALL2 CEP95 MACF1 CNN3	2.91e-04	71	153	5	1.10.418.10
Domain	CH-domain	GAS2 MICALL2 CEP95 MACF1 CNN3	3.76e-04	75	153	5	IPR001715
Domain	CBS_dom	IMPDH2 CLCNKA CLCNKB	5.55e-04	20	153	3	IPR000644
Domain	CBS	IMPDH2 CLCNKA CLCNKB	5.55e-04	20	153	3	PF00571
Domain	CBS	IMPDH2 CLCNKA CLCNKB	5.55e-04	20	153	3	PS51371
Domain	GAR	GAS2 MACF1	9.79e-04	6	153	2	PS51460
Domain	GAS2	GAS2 MACF1	9.79e-04	6	153	2	PF02187
Domain	-	GAS2 MACF1	9.79e-04	6	153	2	3.30.920.20
Domain	GAS_dom	GAS2 MACF1	9.79e-04	6	153	2	IPR003108
Domain	GAS2	GAS2 MACF1	9.79e-04	6	153	2	SM00243
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	RNF169 KIAA0586 ANKRD26 FANCM MYSM1 EFTUD2 ASAP2 POM121 ALMS1 SGPL1 SBF2 LTN1 SCAPER MACF1 PLEKHH2 POM121B FGD6 HERPUD1	1.22e-11	493	157	18	15368895
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	RNF169 SMARCA5 ZNF609 CENPC VEZF1 MAP4 GTSE1 DLGAP5 ZDBF2 MED1 FANCM CWC25 SARNP EMSY HNRNPU EFTUD2 CDCA2 TAF3 SLF2 AHNAK TOP1 TP53BP1 DNMT1	6.50e-11	954	157	23	36373674
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	TICRR SMARCA5 IMPDH2 MAP4 DHX57 SRPK1 TACC2 MED1 GTPBP1 SARNP MAP3K1 HNRNPU CENPQ CDCA2 MAGED2 SCAPER MACF1 TOP1 DNMT1	1.84e-09	759	157	19	35915203
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	TICRR RNF169 SMARCA5 ZNF609 CEBPG VEZF1 FOS DLGAP5 MED1 FANCM DDB2 LIN9 EMSY HNRNPU EFTUD2 CDCA2 RMI1 SLF2 NFE2L2 CCNB2 AHNAK ASXL2 TOP1 DNMT1	4.49e-09	1294	157	24	30804502
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	SMARCA5 IMPDH2 MAP4 DLGAP5 ANKRD26 TACC2 MED1 ANKHD1 EMSY HNRNPU EFTUD2 ALMS1 AHNAK MACF1 HSPA4 TOP1 CNN3 TP53BP1 TP53BP2 DNMT1	9.37e-09	934	157	20	33916271
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	RNF169 SMARCA5 MAP4 SCAF8 KIF1B GTSE1 DLGAP5 MED1 BCL9 EMSY EFTUD2 CCNT2 PACS1 TAF3 MAGED2 TACC3 TP53BP1 DNMT1	1.57e-08	774	157	18	15302935
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	TSHZ3 RNF169 SMARCA5 CENPC VEZF1 DLGAP5 MED1 LIN9 EMSY MYSM1 CDCA2 TAF3 DHCR7 TOP1 SENP7 DNMT1	1.90e-08	608	157	16	36089195
Pubmed	Human transcription factor protein interaction networks.	TSHZ3 SMARCA5 ZNF609 IMPDH2 VEZF1 SCAF8 FOS FBRSL1 BCL9 GTPBP1 ANKHD1 LIN9 EMSY CDCA2 TAF3 ALMS1 MAGED2 SPZ1 GLI3 NCOA1 ASXL2 HSPA4 TOP1 TP53BP1	2.97e-08	1429	157	24	35140242
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	RNF169 ZNF609 SCAF8 DLGAP5 FNDC3A ZDBF2 NCOA4 CWC25 DENND4C JPH1 ALMS1 TBC1D22A SGPL1 DHCR7 CEP295 HERPUD1 DNMT1	4.20e-08	733	157	17	34672954
Pubmed	Charcot-Marie-Tooth Hereditary Neuropathy Overview	KIF1B JPH1 SGPL1 SBF2 MME DNMT1	8.07e-08	48	157	6	20301532
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	TICRR CEBPG MAP4 PPRC1 PEG3 DLGAP5 TACC2 NCOA4 ANKHD1 PACS1 SLC7A1 CLCNKA PIK3CD SGPL1 SBF2 LTN1 MACF1 CEP295 ASXL2 TP53BP1	1.07e-07	1084	157	20	11544199
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	ABR IMPDH2 MAP4 KIF1B ANKRD26 FNDC3A DENND4C HNRNPU JPH1 MAGED2 AHNAK DHCR7 MACF1 HSPA4 TOP1 CNN3	1.52e-07	708	157	16	39231216
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	IMPDH2 MAP4 DHX57 SRPK1 MED1 AHNAK DHCR7 LTN1 DNMT1	3.79e-07	202	157	9	33005030
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	MAP4 KIF1B GTSE1 ANKRD26 DENND1A DENND4C CDCA2 ALMS1 SLF2 CEP95 AHNAK CNKSR3 MACF1 FGD6 MUSK TP53BP2 DNMT1	4.07e-07	861	157	17	36931259
Pubmed	MYC Protein Interactome Profiling Reveals Functionally Distinct Regions that Cooperate to Drive Tumorigenesis.	RNF169 CENPC GTSE1 FBRSL1 ZDBF2 LIN9 EMSY EFTUD2 CDCA2 TOP1 DNMT1	4.53e-07	339	157	11	30415952
Pubmed	Interaction network of human early embryonic transcription factors.	TSHZ3 SMARCA5 ZNF609 FBRSL1 BCL9 LIN9 EMSY TAF3 ALMS1 NCOA1 ASXL2	6.38e-07	351	157	11	38297188
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	ZNF609 CEBPG IMPDH2 VEZF1 MAP4 MED1 BCL9 GTPBP1 SARNP LIN9 EMSY HNRNPU CCNT2 NCOA1 ASXL2 HSPA4 TOP1 TP53BP1 DNMT1	6.42e-07	1103	157	19	34189442
Pubmed	N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.	KIF1B ANKHD1 EMSY HNRNPU PACS1 MAGED2 AHNAK MACF1 HSPA4 CNN3 TP53BP1	8.17e-07	360	157	11	33111431
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	SMARCA5 IMPDH2 CENPC MAP4 DLGAP5 DHX57 SRPK1 ANKHD1 HNRNPU EFTUD2 CDCA2 MAGED2 SGPL1 AHNAK LTN1 MACF1 HSPA4 TOP1 TP53BP1 TP53BP2 DNMT1	8.52e-07	1353	157	21	29467282
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	RNF169 ZNF609 MAP4 GTSE1 TACC2 MED1 EMSY HNRNPU RMI1 MAGED2 SLF2 AHNAK	9.29e-07	444	157	12	34795231
Pubmed	Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.	SRPK1 ANKHD1 ALMS1 NFE2L2 GLI3 NYNRIN SCAPER NCOA1 CEP295	1.25e-06	233	157	9	37704626
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	SMARCA5 MAP4 MED1 ANKHD1 EMSY TAF3 ALMS1 AHNAK TACC3 CNN3 TP53BP1 TP53BP2 DNMT1	1.41e-06	549	157	13	38280479
Pubmed	The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.	GTSE1 UTP23 UST MYSM1 AHNAK MACF1 TACC3 ALPK2 TP53BP2 DNMT1	2.98e-06	332	157	10	37433992
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	ZXDC SMARCA5 ZNF609 VEZF1 FOS PEG3 ID2 SARNP NFE2L2 GLI3 SCAPER NCOA1 MAEL ZNF844 DNMT1	4.28e-06	808	157	15	20412781
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	TSHZ3 ZNF609 AFF2 GTSE1 BCL9 PIP5K1C MAP3K1 ASAP2 POM121 NFE2L2 TP53BP2	4.52e-06	430	157	11	35044719
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	ZNF609 CENPC TACC2 DDB2 LIN9 HNRNPU EFTUD2 JPH1 PACS1 RMI1 SERPINB5 PER2 MICALL2 CCNB2 AHNAK ASXL2 TACC3 TP53BP1	5.21e-06	1155	157	18	20360068
Pubmed	The Eyes Absent family members EYA4 and EYA1 promote PLK1 activation and successful mitosis through tyrosine dephosphorylation.	ZNF609 FBRSL1 BCL9 SCNM1 ALMS1 CCNB2 NCOA1	6.24e-06	152	157	7	38360978
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	KIF1B ANKRD26 DENND1A DENND4C ALMS1 TBC1D22A SGPL1 NYNRIN CEP295 HSPA4 TP53BP2	6.38e-06	446	157	11	24255178
Pubmed	BAG5 Promotes Alpha-Synuclein Oligomer Formation and Functionally Interacts With the Autophagy Adaptor Protein p62.	MAP4 ANKHD1 HNRNPU EFTUD2 AHNAK TACC3 HSPA4	7.41e-06	156	157	7	32850835
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	ABR IMPDH2 DLGAP5 GRIN2A BCL9 TMEM132B EMSY HNRNPU EFTUD2 MAGED2 CNKSR3 MACF1 TACC3 TP53BP1 TP53BP2 DNMT1	8.18e-06	963	157	16	28671696
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	ZNF609 IMPDH2 SCAF8 FBRSL1 DHX57 SRPK1 GTPBP1 ANKHD1 HNRNPU PACS1 SGPL1 CARD6 DNMT1	8.76e-06	650	157	13	38777146
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	ZXDC SEMA3F RIN3 ABR PPRC1 SLC35B3 GTSE1 FBRSL1 BCL9 ANKHD1 PIP5K1C DENND1A SLC7A1 PER2 PIK3CD AHNAK SBF2	1.14e-05	1105	157	17	35748872
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	SMARCA5 ZNF609 ASCC1 FBRSL1 ANKHD1 JPH1 TAF3 ALMS1 CLCNKA SGPL1 GLI3 LTN1 SCAPER MACF1 CEP295 TOP1 SENP7	1.30e-05	1116	157	17	31753913
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	SLC12A6 ZNF609 ABR MAP4 SCAF8 FLVCR1 KIF1B FBRSL1 LRRC8D DENND1A HNRNPU PACS1 SLC7A1 ASAP2 TMEM242 TBC1D22A SBF2 TTC12 MACF1 MME	1.35e-05	1489	157	20	28611215
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	SMARCA5 VEZF1 MAP4 PEG3 MRPL58 DHX57 SRPK1 MED1 GTPBP1 ANKHD1 CWC25 DENND1A MAP3K1 TAF3 MAGED2 AHNAK DHCR7 TOP1 DNMT1	1.47e-05	1371	157	19	36244648
Pubmed	USP7 Regulates Cytokinesis through FBXO38 and KIF20B.	ZXDC TICRR TSHZ3 RNF169 LIN9 DNMT1	1.52e-05	116	157	6	30804394
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	KIF1B FBRSL1 ANKRD26 TACC2 ZDBF2 EMSY RMI1 ALMS1 SLF2 CCNB2 MACF1 TP53BP1	1.61e-05	588	157	12	38580884
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	PPRC1 SCAF8 KIF1B PEG3 PIP5K1C SNX19 PER2 MACF1 ASXL2 SENP7	1.76e-05	407	157	10	12693553
Pubmed	Fibril treatment changes protein interactions of tau and α-synuclein in human neurons.	SMARCA5 MAP4 PCLO GTPBP1 HNRNPU MAGED2 SGPL1 AHNAK MACF1 TOP1 CNN3	1.78e-05	498	157	11	36634849
Pubmed	AHNAK controls 53BP1-mediated p53 response by restraining 53BP1 oligomerization and phase separation.	AHNAK TP53BP1	2.02e-05	2	157	2	33961796
Pubmed	The ClC-K2 Chloride Channel Is Critical for Salt Handling in the Distal Nephron.	CLCNKA CLCNKB	2.02e-05	2	157	2	27335120
Pubmed	MEKK1-dependent phosphorylation of calponin-3 tunes cell contractility.	MAP3K1 CNN3	2.02e-05	2	157	2	27528401
Pubmed	Assignment of the genes encoding the human chloride channels, CLCNKA and CLCNKB, to 1p36 and of CLCN3 to 4q32-q33 by in situ hybridization.	CLCNKA CLCNKB	2.02e-05	2	157	2	8812470
Pubmed	Associations between CLCNKA_B tag SNPs with essential hypertension and interactions between genetic and environmental factors in an island population in China.	CLCNKA CLCNKB	2.02e-05	2	157	2	25919862
Pubmed	Epigenetic control of natural killer cell maturation by histone H2A deubiquitinase, MYSM1.	ID2 MYSM1	2.02e-05	2	157	2	24062447
Pubmed	Expanding Genotype-Phenotype Correlation of CLCNKA and CLCNKB Variants Linked to Hearing Loss.	CLCNKA CLCNKB	2.02e-05	2	157	2	38069401
Pubmed	The centrosomal protein TACC3 is essential for hematopoietic stem cell function and genetically interfaces with p53-regulated apoptosis.	TACC2 TACC3	2.02e-05	2	157	2	11847113
Pubmed	Cloning of the cDNA encoding human C/EBP gamma, a protein binding to the PRE-I enhancer element of the human interleukin-4 promoter.	CEBPG FOS	2.02e-05	2	157	2	7665092
Pubmed	A regulatory calcium-binding site at the subunit interface of CLC-K kidney chloride channels.	CLCNKA CLCNKB	2.02e-05	2	157	2	20805576
Pubmed	The microtubule-associated protein HURP recruits the centrosomal protein TACC3 to regulate K-fiber formation and support chromosome congression.	DLGAP5 TACC3	2.02e-05	2	157	2	30054275
Pubmed	Inhibitor of DNA binding 2 (Id2) Regulates Photic Entrainment Responses in Mice: Differential Responses of the Id2-/- Mouse Circadian System Are Dependent on Circadian Phase and on Duration and Intensity of Light.	ID2 PER2	2.02e-05	2	157	2	32981454
Pubmed	Salt wasting and deafness resulting from mutations in two chloride channels.	CLCNKA CLCNKB	2.02e-05	2	157	2	15044642
Pubmed	Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.	PEG3 DIRAS3	2.02e-05	2	157	2	18286529
Pubmed	Two highly homologous members of the ClC chloride channel family in both rat and human kidney.	CLCNKA CLCNKB	2.02e-05	2	157	2	8041726
Pubmed	The Association of a Genetic Variant in SCAF8-CNKSR3 with Diabetic Kidney Disease and Diabetic Retinopathy in a Chinese Population.	SCAF8 CNKSR3	2.02e-05	2	157	2	28401168
Pubmed	A cytoplasmic domain mutation in ClC-Kb affects long-distance communication across the membrane.	CLCNKA CLCNKB	2.02e-05	2	157	2	18648499
Pubmed	Stimulation of p53-mediated transcriptional activation by the p53-binding proteins, 53BP1 and 53BP2.	TP53BP1 TP53BP2	2.02e-05	2	157	2	9748285
Pubmed	Cloning, tissue distribution, and intrarenal localization of ClC chloride channels in human kidney.	CLCNKA CLCNKB	2.02e-05	2	157	2	8544406
Pubmed	The Expression of Gli3 and Teashirt3 in the Stenotic Tissue of Congenital Pelvi-Ureteric Junction Obstruction in Children.	TSHZ3 GLI3	2.02e-05	2	157	2	27279789
Pubmed	Targeting kidney CLC-K channels: pharmacological profile in a human cell line versus Xenopus oocytes.	CLCNKA CLCNKB	2.02e-05	2	157	2	24863058
Pubmed	Overt nephrogenic diabetes insipidus in mice lacking the CLC-K1 chloride channel.	CLCNKA CLCNKB	2.02e-05	2	157	2	9916798
Pubmed	Kidney kinetics and chloride ion pumps.	CLCNKA CLCNKB	2.02e-05	2	157	2	9916791
Pubmed	Id2 promotes tumor cell migration and invasion through transcriptional repression of semaphorin 3F.	SEMA3F ID2	2.02e-05	2	157	2	20388805
Pubmed	Nrf2 protects against cartilage endplate degeneration through inhibiting NCOA4‑mediated ferritinophagy.	NCOA4 NFE2L2	2.02e-05	2	157	2	38063237
Pubmed	Impaired long-term memory and NR2A-type NMDA receptor-dependent synaptic plasticity in mice lacking c-Fos in the CNS.	FOS GRIN2A	2.02e-05	2	157	2	14534245
Pubmed	A fear-inducing odor alters PER2 and c-Fos expression in brain regions involved in fear memory.	FOS PER2	2.02e-05	2	157	2	21655193
Pubmed	Response of the brain to oligemia: gene expression, c-Fos, and Nrf2 localization.	FOS NFE2L2	2.02e-05	2	157	2	15207916
Pubmed	Effects of chromatin structure on the enzymatic and DNA binding functions of DNA methyltransferases DNMT1 and Dnmt3a in vitro.	SMARCA5 DNMT1	2.02e-05	2	157	2	15313181
Pubmed	ALMS1 and Alström syndrome: a recessive form of metabolic, neurosensory and cardiac deficits.	ALMS1 CEP295	2.02e-05	2	157	2	30421101
Pubmed	TACC3 expression is tightly regulated during early differentiation.	TACC2 TACC3	2.02e-05	2	157	2	12711550
Pubmed	Cl(-) channels in basolateral TAL membranes XV. Molecular heterogeneity between cortical and medullary channels.	CLCNKA CLCNKB	2.02e-05	2	157	2	11014860
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	TSHZ3 ZNF609 ZDBF2 ANKHD1 LIN9 DENND4C ALMS1 AHNAK TACC3 TP53BP2	2.20e-05	418	157	10	34709266
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	ZNF609 ABR MAP4 ASCC1 ANKRD26 DHX57 MED1 GTPBP1 ANKHD1 AHNAK MACF1 TOP1 CNN3	2.71e-05	724	157	13	36232890
Pubmed	Interactome study suggests multiple cellular functions of hepatoma-derived growth factor (HDGF).	SMARCA5 MAP4 SRPK1 GTPBP1 HNRNPU EFTUD2 TOP1	2.75e-05	191	157	7	21907836
Pubmed	Automated yeast two-hybrid screening for nuclear receptor-interacting proteins.	ZXDC MAP4 MED1 NCOA4 NCOA1 MACF1	3.29e-05	133	157	6	15604093
Pubmed	The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery.	ZNF609 IMPDH2 CENPC VEZF1 FNDC3A DDB2 HNRNPU EFTUD2 CCNT2 SLC7A1 SGPL1 GLI3 AHNAK DHCR7 HERPUD1 TOP1 TP53BP1	3.35e-05	1203	157	17	29180619
Pubmed	Targeted and Interactome Proteomics Revealed the Role of PHD2 in Regulating BRD4 Proline Hydroxylation.	SMARCA5 MAP4 DLGAP5 MED1 SARNP HNRNPU EFTUD2 HSPA4 TOP1 DNMT1	3.47e-05	441	157	10	31239290
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	SMARCA5 IMPDH2 MAP4 DHX57 SRPK1 ANKHD1 AHNAK MACF1 HSPA4 TOP1 TP53BP1 DNMT1	4.46e-05	653	157	12	22586326
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	KIAA0586 ZDBF2 DENND4C ALMS1 MAGED2 MACF1 TP53BP2	4.87e-05	209	157	7	36779422
Pubmed	Novel asymmetrically localizing components of human centrosomes identified by complementary proteomics methods.	KIAA0586 ANKRD26 ALMS1 CCNB2 CEP95 CEP295	5.54e-05	146	157	6	21399614
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	AFF2 FLVCR1 KIF1B ANKRD26 MUC16 EFTUD2 CDCA2 MAGED2 GLI3 AHNAK DHCR7 TACC3 DNMT1	5.57e-05	777	157	13	35844135
Pubmed	Human CLC-K Channels Require Palmitoylation of Their Accessory Subunit Barttin to Be Functional.	CLCNKA CLCNKB	6.06e-05	3	157	2	26013830
Pubmed	Spermatid-specific expression of the novel X-linked gene product SPAN-X localized to the nucleus of human spermatozoa.	SPANXA1 SPANXB1	6.06e-05	3	157	2	10906052
Pubmed	Barttin increases surface expression and changes current properties of ClC-K channels.	CLCNKA CLCNKB	6.06e-05	3	157	2	12111250
Pubmed	Defining the molecular interface that connects the Fanconi anemia protein FANCM to the Bloom syndrome dissolvasome.	FANCM RMI1	6.06e-05	3	157	2	22392978
Pubmed	Modifiers of epigenetic reprogramming show paternal effects in the mouse.	SMARCA5 DNMT1	6.06e-05	3	157	2	17450140
Pubmed	POM121 inhibits the macrophage inflammatory response by impacting NF-κB P65 nuclear accumulation.	POM121 POM121B	6.06e-05	3	157	2	30802453
Pubmed	The TACC domain identifies a family of centrosomal proteins that can interact with microtubules.	TACC2 TACC3	6.06e-05	3	157	2	11121038
Pubmed	Integrative analysis of the cancer genome atlas and cancer cell lines encyclopedia large-scale genomic databases: MUC4/MUC16/MUC20 signature is associated with poor survival in human carcinomas.	MUC16 MUC20	6.06e-05	3	157	2	30236127
Pubmed	Common genetic variants and haplotypes in renal CLCNKA gene are associated to salt-sensitive hypertension.	CLCNKA CLCNKB	6.06e-05	3	157	2	17510212
Pubmed	Oncogenic KRAS drives radioresistance through upregulation of NRF2-53BP1-mediated non-homologous end-joining repair.	NFE2L2 TP53BP1	6.06e-05	3	157	2	34606602
Pubmed	Nucleoporin POM121 signals TFEB-mediated autophagy via activation of SIGMAR1/sigma-1 receptor chaperone by pridopidine.	POM121 POM121B	6.06e-05	3	157	2	35507432
Pubmed	The centrosomal, putative tumor suppressor protein TACC2 is dispensable for normal development, and deficiency does not lead to cancer.	TACC2 TACC3	6.06e-05	3	157	2	15226440
Pubmed	Differential Expression of MUC12, MUC16, and MUC20 in Patients with Active and Remission Ulcerative Colitis.	MUC16 MUC20	6.06e-05	3	157	2	26770020
Pubmed	A novel mutation in helix 12 of the vitamin D receptor impairs coactivator interaction and causes hereditary 1,25-dihydroxyvitamin D-resistant rickets without alopecia.	MED1 NCOA1	6.06e-05	3	157	2	12403843
Pubmed	Steroid receptor coactivator-1 coactivates activating protein-1-mediated transactivations through interaction with the c-Jun and c-Fos subunits.	FOS NCOA1	6.06e-05	3	157	2	9642216
Pubmed	CDCA2 protects against oxidative stress by promoting BRCA1-NRF2 signaling in hepatocellular carcinoma.	CDCA2 NFE2L2	6.06e-05	3	157	2	34103686
Pubmed	Barttin modulates trafficking and function of ClC-K channels.	CLCNKA CLCNKB	6.06e-05	3	157	2	16849430
Pubmed	Mechanisms of Disease: the kidney-specific chloride channels ClCKA and ClCKB, the Barttin subunit, and their clinical relevance.	CLCNKA CLCNKB	6.06e-05	3	157	2	18094726
Pubmed	Transcriptional regulation of the CLC-K1 promoter by myc-associated zinc finger protein and kidney-enriched Krüppel-like factor, a novel zinc finger repressor.	CLCNKA CLCNKB	6.06e-05	3	157	2	10982849
Interaction	HECTD1 interactions	TICRR RIN3 SMARCA5 IMPDH2 MAP4 SCAF8 DHX57 SRPK1 TACC2 MED1 GTPBP1 SARNP DIRAS3 MAP3K1 HNRNPU CENPQ EFTUD2 CDCA2 MAGED2 SCAPER MACF1 HSPA4 TOP1 DNMT1	5.15e-07	984	155	24	int:HECTD1
Interaction	HERC2 interactions	ABR MAP4 GTSE1 SRPK1 FNDC3A GRIN2A MED1 NCOA4 SARNP RMI1 SPZ1 MACF1 SAMD3 TACC3 TOP1 TP53BP1	1.76e-06	503	155	16	int:HERC2
Interaction	SMC5 interactions	RNF169 SMARCA5 ZNF609 CENPC VEZF1 MAP4 GTSE1 DLGAP5 ZDBF2 MED1 FANCM CWC25 SARNP EMSY HNRNPU EFTUD2 CDCA2 TAF3 SLF2 AHNAK TOP1 TP53BP1 DNMT1	2.48e-06	1000	155	23	int:SMC5
Interaction	BRCA1 interactions	RNF169 SMARCA5 IMPDH2 MAP4 KIF1B PEG3 ANKRD26 FANCM EMSY MAP3K1 HNRNPU EFTUD2 CDCA2 RMI1 POM121 ALMS1 SLF2 NFE2L2 AHNAK NCOA1 TACC3 HSPA4 TOP1 TP53BP1 DNMT1	9.98e-06	1249	155	25	int:BRCA1
Interaction	H1-5 interactions	CENPC MAP4 ANKRD26 UTP23 DHX57 ZDBF2 CCDC168 EMSY HNRNPU CENPQ EFTUD2 ASAP2 MICALL2 WDR87	1.42e-05	463	155	14	int:H1-5
Interaction	LRRC31 interactions	IMPDH2 MAP4 DHX57 SRPK1 MED1 AHNAK DHCR7 LTN1 DNMT1	3.05e-05	205	155	9	int:LRRC31
Interaction	CENPA interactions	TSHZ3 RNF169 SMARCA5 CENPC MYSM1 HNRNPU CENPQ CDCA2 TAF3 SLF2 TOP1 DNMT1	3.63e-05	377	155	12	int:CENPA
Interaction	YWHAH interactions	TICRR RIN3 KIF1B GTSE1 ANKRD26 MED1 DENND1A DENND4C EFTUD2 CDCA2 PACS1 ALMS1 SLF2 CEP95 AHNAK CNKSR3 NCOA1 MACF1 FGD6 HSPA4 TP53BP2 DNMT1	3.77e-05	1102	155	22	int:YWHAH
Interaction	CBX3 interactions	RNF169 SMARCA5 CENPC VEZF1 SRPK1 MED1 MYSM1 HNRNPU EFTUD2 CDCA2 MACF1 ASXL2 TOP1 TP53BP1 SENP7 DNMT1	3.96e-05	646	155	16	int:CBX3
Interaction	KCNA3 interactions	ABR AFF2 IMPDH2 MAP4 KIF1B ANKRD26 FNDC3A DENND4C HNRNPU JPH1 ASAP2 MAGED2 CEP95 AHNAK DHCR7 MACF1 HSPA4 TOP1 CNN3	4.14e-05	871	155	19	int:KCNA3
Interaction	YY1 interactions	SMARCA5 FOS ID2 LIN9 EMSY EFTUD2 CDCA2 CCNT2 TAF3 NFE2L2 ASXL2 HSPA4 TOP1	5.09e-05	454	155	13	int:YY1
Interaction	NAA40 interactions	SMARCA5 IMPDH2 MAP4 DLGAP5 ANKRD26 TACC2 MED1 ANKHD1 EMSY HNRNPU EFTUD2 ALMS1 AHNAK MACF1 HSPA4 TOP1 CNN3 TP53BP1 TP53BP2 DNMT1	6.31e-05	978	155	20	int:NAA40
Interaction	H3C1 interactions	RNF169 SMARCA5 CENPC DLGAP5 SRPK1 SARNP DDB2 MYSM1 HNRNPU EFTUD2 CDCA2 TAF3 MICALL2 NFE2L2 WDR87 AHNAK TOP1 TP53BP1 DNMT1	6.51e-05	901	155	19	int:H3C1
GeneFamily	Guanylate cyclase receptors\|DENN/MADD domain containing	DENND1A DENND4C SBF2	3.26e-04	25	98	3	504
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	ABR KIF1B ASAP2 SBF2 PLEKHH2 FGD6	8.97e-04	206	98	6	682
GeneFamily	Chloride voltage-gated channels	CLCNKA CLCNKB	1.27e-03	10	98	2	302
GeneFamily	Basic leucine zipper proteins	CEBPG FOS NFE2L2	2.37e-03	49	98	3	506
Coexpression	HE_LIM_SUN_FETAL_LUNG_C6_DEUTEROSOMAL_CELL	DLGAP5 ZDBF2 FANCM LIN9 RMI1 ASAP2 CCNB2 CEP295 TACC3	7.47e-06	221	156	9	M45789
Coexpression	FISCHER_DREAM_TARGETS	TICRR SMARCA5 CENPC GTSE1 DLGAP5 FANCM LIN9 HNRNPU CENPQ CDCA2 RMI1 ALMS1 SLF2 CCNB2 CEP295 TACC3 TOP1 DNMT1	1.98e-05	969	156	18	M149
Coexpression	GSE19941_UNSTIM_VS_LPS_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_UP	ZXDC TICRR RIN3 CDCA2 SLF2 CCNB2 FGD6 TP53BP1	2.66e-05	199	156	8	M8103
Coexpression	GSE14350_TREG_VS_TEFF_IN_IL2RB_KO_UP	ABR SLC35B3 SRPK1 MED1 ANKHD1 DDB2 CCNT2 ASXL2	2.76e-05	200	156	8	M3419
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3	SMARCA5 ANKRD26 ZDBF2 LRRC8D HNRNPU CENPQ ALMS1 GLI3 CEP295 FGD6 HSPA4 TOP1 MAP3K19	1.42e-09	192	153	13	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5	ANKRD26 ZDBF2 BCL9 LRRC8D LIN9 HNRNPU TAF3 ALMS1 SLF2 MACF1 HSPA4 TOP1	1.08e-08	186	153	12	Facebase_RNAseq_e10.5_Mandibular Arch_500_K5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3	TICRR SMARCA5 AFF2 NCOA4 BCL9 HNRNPU TAF3 SLF2 NFE2L2 GLI3 MACF1 CEP295 ASXL2 FGD6 HSPA4 TOP1 MAP3K19	1.57e-08	432	153	17	Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2	SMARCA5 KIAA0586 ANKRD26 ANKHD1 LRRC8D LIN9 HNRNPU ALMS1 GLI3 CEP295 FGD6 HSPA4 TOP1 MAP3K19	6.02e-08	311	153	14	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3	TICRR AFF2 KIAA0586 ANKRD26 DHX57 NCOA4 EMSY CENPQ NFE2L2 MACF1 FGD6 HSPA4 TOP1	1.99e-07	291	153	13	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3
CoexpressionAtlas	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4	TICRR SMARCA5 ZNF609 AFF2 CENPC VEZF1 KIF1B PEG3 KIAA0586 FBRSL1 ANKRD26 SRPK1 ZDBF2 BCL9 FANCM LRRC8D LIN9 EMSY HNRNPU CDCA2 RMI1 ALMS1 CEP95 CEP295 HSPA4 TOP1 TP53BP1 SENP7	4.90e-07	1370	153	28	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000	SEMA3F TICRR COL6A3 ABR AFF2 PCLO KIAA0586 FBRSL1 ANKRD26 UTP23 DHX57 NCOA4 LIN9 EMSY CENPQ JPH1 NFE2L2 MACF1 MME FGD6 HSPA4 TOP1 SENP7	6.29e-07	985	153	23	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4	PCLO KIAA0586 ANKRD26 NCOA4 LIN9 CENPQ JPH1 MACF1 HSPA4 TOP1	1.35e-06	192	153	10	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000	TICRR SMARCA5 AFF2 PCLO MRPL58 NCOA4 BCL9 LIN9 HNRNPU TAF3 SLF2 NFE2L2 GLI3 MACF1 CEP295 ASXL2 TACC3 FGD6 HSPA4 TOP1 SENP7 MAP3K19	2.51e-06	989	153	22	Facebase_RNAseq_e10.5_Maxillary Arch_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500	AFF2 ANKRD26 ZDBF2 BCL9 LRRC8D LIN9 HNRNPU TAF3 ALMS1 SLF2 MACF1 FGD6 HSPA4 TOP1 MAP3K19	2.86e-06	492	153	15	Facebase_RNAseq_e10.5_Mandibular Arch_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#3	AFF2 ANKRD26 ZDBF2 LRRC8D LIN9 HNRNPU CDCA2 ALMS1 MACF1 HSPA4 SENP7	4.50e-06	271	153	11	Facebase_RNAseq_e10.5_Mandibular Arch_1000_K3
CoexpressionAtlas	FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3	SMARCA5 CENPC PCLO ANKRD26 ZDBF2 FANCM HNRNPU CENPQ CDCA2 POM121 ALMS1 GLI3 HSPA4 TOP1 DNMT1	7.34e-06	532	153	15	Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3
CoexpressionAtlas	facebase_RNAseq_e10.5_MaxArch_2500_K3	TICRR SMARCA5 CENPC ANKRD26 BCL9 FANCM SARNP LIN9 EMSY HNRNPU CENPQ CDCA2 IGSF10 TAF3 ALMS1 NFE2L2 CCNB2 GLI3 CEP295 ASXL2 FGD6 HSPA4 TOP1 SENP7	1.06e-05	1252	153	24	facebase_RNAseq_e10.5_MaxArch_2500_K3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5	SMARCA5 KIAA0586 DLGAP5 FNDC3A NCOA4 LIN9 HNRNPU TAF3 SLF2 GLI3 MACF1 CEP295 ASXL2 HSPA4 TOP1 MAP3K19	1.30e-05	629	153	16	Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1	TICRR MAP4 KIAA0586 ANKRD26 DHX57 NCOA4 ANKHD1 LIN9 EMSY DENND4C CENPQ NFE2L2 CCNB2 CEP95 SGPL1 MACF1 HSPA4 TOP1	1.36e-05	780	153	18	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500	SMARCA5 PCLO ANKRD26 ZDBF2 LRRC8D HNRNPU CENPQ ALMS1 GLI3 CEP295 FGD6 HSPA4 TOP1 MAP3K19	1.55e-05	498	153	14	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500
CoexpressionAtlas	FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#4	SMARCA5 KIAA0586 FNDC3A NCOA4 FANCM LIN9 SLF2 MACF1 ASXL2	1.70e-05	203	153	9	Facebase_RNAseq_e9.5_Mandibular Arch_1000_K4
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000	COL6A3 AFF2 ANKRD26 ZDBF2 BCL9 LRRC8D LIN9 HNRNPU CDCA2 IGSF10 TAF3 ALMS1 SLF2 MACF1 MME FGD6 HSPA4 TOP1 SENP7 MAP3K19	2.53e-05	978	153	20	Facebase_RNAseq_e10.5_Mandibular Arch_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5	SMARCA5 PCLO KIAA0586 ANKRD26 DHX57 ZDBF2 ANKHD1 LRRC8D LIN9 HNRNPU JPH1 ALMS1 SGPL1 GLI3 CEP295 HSPA4 TOP1 MAP3K19	3.15e-05	831	153	18	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5
CoexpressionAtlas	DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_1000	MAP4 KIF1B KIAA0586 FNDC3A MYSM1 MAP3K1 CDCA2 CEP295 TOP1 SENP7	3.38e-05	277	153	10	gudmap_developingGonad_e12.5_ovary_k3_1000
CoexpressionAtlas	DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000	SMARCA5 MAP4 KIF1B PEG3 ANKRD26 ANKHD1 DDB2 MYSM1 SYCP2 ALMS1 SGPL1 SCAPER MAEL CEP295 ASXL2 TOP1 SENP7	4.61e-05	776	153	17	gudmap_developingGonad_e14.5_ ovary_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500	PCLO KIAA0586 ANKRD26 NCOA4 LIN9 CENPQ JPH1 MACF1 MME FGD6 HSPA4 TOP1 SENP7	5.95e-05	492	153	13	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4	SMARCA5 PCLO KIAA0586 ZDBF2 LRRC8D HNRNPU JPH1 ALMS1 NCOA1 HSPA4	6.25e-05	298	153	10	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4
CoexpressionAtlas	FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4	TICRR COL6A3 BCL9 CENPQ GLI3 SCAPER MACF1 FGD6 HSPA4 TOP1	6.25e-05	298	153	10	Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4
CoexpressionAtlas	dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500	COL6A3 AFF2 PEG3 MUC16 GRIN2A IGSF10 GLI3 NYNRIN EGFLAM MME PLEKHH2	6.40e-05	361	153	11	gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_500
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_MedNas_2500_K1	TICRR SMARCA5 CENPC KIAA0586 ANKRD26 ZDBF2 BCL9 FANCM CWC25 EMSY HNRNPU CDCA2 ALMS1 PIK3CD GLI3 MACF1 CEP295 HSPA4 TOP1 TP53BP1	7.77e-05	1060	153	20	facebase_RNAseq_e10.5_Emin_MedNas_2500_K1
CoexpressionAtlas	facebase_RNAseq_e10.5_MandArch_2500_K1	TICRR SMARCA5 AFF2 CENPC PEG3 ANKRD26 ZDBF2 BCL9 FANCM LIN9 EMSY HNRNPU CENPQ CDCA2 IGSF10 ALMS1 SLF2 GLI3 MACF1 CEP295 HSPA4 TOP1	8.29e-05	1241	153	22	facebase_RNAseq_e10.5_MandArch_2500_K1
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000	SMARCA5 PCLO KIAA0586 ANKRD26 MANEA ZDBF2 ANKHD1 LRRC8D LIN9 HNRNPU CENPQ ALMS1 NSG2 GLI3 CEP295 FGD6 HSPA4 TOP1 MAP3K19	9.40e-05	989	153	19	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_500_k-means-cluster#3	TICRR SMARCA5 AFF2 BCL9 NFE2L2 GLI3 HSPA4 TOP1 MAP3K19	1.00e-04	255	153	9	Facebase_RNAseq_e10.5_Maxillary Arch_500_K3
CoexpressionAtlas	dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000	TICRR COL6A3 AFF2 FOS PEG3 DLGAP5 ID2 MUC16 ZDBF2 BCL9 CENPQ SLF2 GLI3 NYNRIN LTN1 MME PLEKHH2	1.00e-04	827	153	17	gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_1000	MAP4 KIF1B KIAA0586 MYSM1 MAP3K1 CDCA2 CEP295 TOP1 SENP7	1.13e-04	259	153	9	gudmap_developingGonad_e12.5_epididymis_k3_1000
CoexpressionAtlas	dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500	COL6A3 FOS MUC16 ZDBF2 GLI3 NYNRIN MME PLEKHH2	1.32e-04	207	153	8	gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_500
CoexpressionAtlas	dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000	COL6A3 AFF2 FOS PEG3 DLGAP5 MUC16 ZDBF2 GRIN2A IGSF10 SLF2 NYNRIN DHCR7 LTN1 EGFLAM MME PLEKHH2	1.50e-04	773	153	16	gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000
CoexpressionAtlas	dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_1000	COL6A3 FOS ID2 MUC16 ZDBF2 BCL9 GLI3 NYNRIN MME PLEKHH2	1.72e-04	337	153	10	gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k1_1000
CoexpressionAtlas	Ectoderm Differentiated Cells_vs_Mesoderm Day 5-Confounder_removed-fold2.0_adjp0.05	CENPC KIAA0586 ID2 FNDC3A TACC2 ZDBF2 HSD11B1L LRRC4 LRRC8D UST DENND1A DDB2 EMSY ASAP2 MAMDC2 GLI3 CNKSR3 AP5M1	2.14e-04	967	153	18	PCBC_ratio_ECTO_vs_MESO-5_cfr-2X-p05
CoexpressionAtlas	FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2	SMARCA5 KIAA0586 FNDC3A NCOA4 FANCM LIN9 TAF3 ASAP2 SLF2 MACF1 ASXL2 FGD6 CNN3	2.30e-04	564	153	13	Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2
CoexpressionAtlas	DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000	SMARCA5 MAP4 KIF1B PEG3 KIAA0586 ANKRD26 FNDC3A NCOA4 MYSM1 MAP3K1 CDCA2 MAEL CEP295 ASXL2 TOP1 SENP7	2.34e-04	804	153	16	gudmap_developingGonad_e12.5_ovary_1000
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#3_top-relative-expression-ranked_500	COL6A3 FOS MUC16 IGSF10 NYNRIN MME	2.58e-04	122	153	6	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k3_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000	ZXDC COL6A3 SMARCA5 PCLO ANKRD26 ZDBF2 BCL9 FANCM LRRC8D HNRNPU JPH1 ALMS1 GLI3 SCAPER MME HSPA4 TOP1 SENP7	2.62e-04	983	153	18	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000
CoexpressionAtlas	FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000	SMARCA5 ZNF609 PPRC1 PEG3 KIAA0586 MRPL58 SRPK1 FNDC3A NCOA4 FANCM LIN9 EFTUD2 SLF2 AHNAK MACF1 ASXL2 TACC3 TP53BP1	2.62e-04	983	153	18	Facebase_RNAseq_e9.5_Mandibular Arch_1000
CoexpressionAtlas	dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_500	COL6A3 AFF2 PEG3 MUC16 ZDBF2 GRIN2A IGSF10 NYNRIN EGFLAM MME	2.66e-04	356	153	10	gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000	SMARCA5 ZNF609 AFF2 CENPC PCLO KIF1B KIAA0586 ZDBF2 FANCM LRRC8D HNRNPU JPH1 ALMS1 NCOA1 MACF1 HSPA4 TOP1 SENP7	2.71e-04	986	153	18	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_500	COL6A3 AFF2 FOS PEG3 MUC16 DENND4C IGSF10 SLF2 NYNRIN MME	2.72e-04	357	153	10	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_500
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3	TICRR SMARCA5 CENPC KIAA0586 ANKRD26 ZDBF2 BCL9 FANCM LIN9 EMSY HNRNPU CENPQ CDCA2 ALMS1 GLI3 MACF1 CEP295 HSPA4 TOP1 TP53BP1 DNMT1	2.75e-04	1257	153	21	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5	SMARCA5 ZDBF2 LRRC8D HNRNPU JPH1 GLI3 HSPA4 TOP1	2.86e-04	232	153	8	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5
CoexpressionAtlas	dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000	AFF2 FOS PEG3 SLF2 NYNRIN PLEKHH2	2.94e-04	125	153	6	gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k1_1000
CoexpressionAtlas	facebase_RNAseq_e10.5_MandArch_2500	TICRR SMARCA5 AFF2 CENPC FOS PEG3 ANKRD26 ZDBF2 BCL9 FANCM LIN9 EMSY HNRNPU CENPQ CDCA2 IGSF10 ALMS1 SLF2 GLI3 MACF1 CEP295 HSPA4 TOP1	3.46e-04	1468	153	23	facebase_RNAseq_e10.5_MandArch_2500
CoexpressionAtlas	dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#4_top-relative-expression-ranked_500	COL6A3 ZDBF2 GRIN2A IGSF10 NYNRIN EGFLAM MME	3.59e-04	182	153	7	gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k4_500
CoexpressionAtlas	gamma delta T cells, Tgd.vg1+vd6+.Th, TCRd+ Vd6.3+ Vg1.1+, Thymus, avg-1	IMPDH2 DLGAP5 ID2 TACC2 CDCA2 NSG2 CCNB2 SAMD3 TACC3	4.07e-04	308	153	9	GSM605775_500
CoexpressionAtlas	dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#3_top-relative-expression-ranked_1000	FOS ID2 MUC16 ZDBF2 BCL9 IGSF10 GLI3 MME PLEKHH2	4.36e-04	311	153	9	gudmap_dev gonad_e11.5_M_GonMes_Sma_k3_1000
CoexpressionAtlas	B cells, preB.FrD.BM, CD19+ IgM- CD45R+ CD43-, Bone marrow, avg-3	SLC12A6 TICRR DLGAP5 MANEA CDCA2 CCNB2 TACC3 FGD6 HERPUD1 CNN3	4.74e-04	383	153	10	GSM399448_500
CoexpressionAtlas	dev gonad_e11.5_F_GonMes_Sma_k-means-cluster#4_top-relative-expression-ranked_1000	FOS ID2 MUC16 ZDBF2 BCL9 GLI3 NYNRIN MME PLEKHH2	6.26e-04	327	153	9	gudmap_dev gonad_e11.5_F_GonMes_Sma_k4_1000
CoexpressionAtlas	alpha beta T cells, T.DPbl.Th, 4+ 8+ TCR-/lo FSChi, Thymus, avg-3	TICRR CENPC GTSE1 DLGAP5 LIN9 CDCA2 ALMS1 NSG2 CCNB2 TACC3	6.38e-04	398	153	10	GSM399397_500
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#2_top-relative-expression-ranked_1000	COL6A3 FOS ID2 MUC16 IGSF10 NYNRIN MME PLEKHH2	6.90e-04	265	153	8	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k2_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_M-2fold-vs-F_top305_305	ZXDC KIF1B PEG3 LIN9 CCNT2 SERPINB5 ASXL2 TOP1	7.07e-04	266	153	8	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_250_M-vs-F-2X
CoexpressionAtlas	FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#5	PCLO ZDBF2 FANCM HNRNPU CENPQ HSPA4 TOP1	7.08e-04	204	153	7	Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K5
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500	TICRR SMARCA5 AFF2 CENPC KIAA0586 ANKRD26 ZDBF2 BCL9 FANCM LIN9 EMSY HNRNPU CENPQ CDCA2 ALMS1 GLI3 MACF1 CEP295 HSPA4 TOP1 TP53BP1 DNMT1	7.85e-04	1459	153	22	facebase_RNAseq_e10.5_Emin_LatNas_2500
CoexpressionAtlas	NK cells, NK.Sp, NK1.1+, Spleen, avg-3	TSHZ3 VEZF1 KIF1B ID2 UST PACS1 ASAP2 AHNAK CARD6 SAMD3	7.85e-04	409	153	10	GSM538315_500
CoexpressionAtlas	facebase_RNAseq_e8.5_FloorPlate_2500_K3	TICRR SMARCA5 PPRC1 ANKRD26 SRPK1 ZDBF2 BCL9 FANCM LRRC4 DENND1A LIN9 EMSY CDCA2 POM121 ALMS1 CCNB2 PIK3CD GLI3 TTC12 HSPA4 TOP1	8.54e-04	1371	153	21	facebase_RNAseq_e8.5_FloorPlate_2500_K3
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000	MAP4 KIF1B FNDC3A MYSM1 MAP3K1 CEP295 TOP1 SENP7	8.78e-04	275	153	8	gudmap_developingGonad_e14.5_ epididymis_1000_k3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_500	TICRR SMARCA5 AFF2 PCLO BCL9 NFE2L2 GLI3 HSPA4 TOP1 SENP7 MAP3K19	9.00e-04	492	153	11	Facebase_RNAseq_e10.5_Maxillary Arch_500
CoexpressionAtlas	alpha beta T cells, T.ISP.Th, 4- 8+ TCR-/lo 24hi, Thymus, avg-3	TICRR IMPDH2 GTSE1 DLGAP5 FANCM CDCA2 ALMS1 NSG2 CCNB2 TACC3	9.10e-04	417	153	10	GSM399403_500
CoexpressionAtlas	dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_500	COL6A3 FOS PEG3 MUC16 ZDBF2 GLI3 NYNRIN LTN1 MME PLEKHH2	9.27e-04	418	153	10	gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_500
CoexpressionAtlas	dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#1_top-relative-expression-ranked_500	COL6A3 GRIN2A IGSF10 NYNRIN EGFLAM MME	9.49e-04	156	153	6	gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k1_500
CoexpressionAtlas	dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_1000	AFF2 FOS PEG3 DLGAP5 ID2 MUC16 ZDBF2 BCL9 CENPQ SLF2 GLI3 NYNRIN LTN1 MME PLEKHH2	1.00e-03	831	153	15	gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_1000
CoexpressionAtlas	B cells, B.Fo.PC, IgD+ IgM+ CD19+ CD43- CD5- CD23+, Peritoneal Cavity, avg-3	SLC12A6 DHX57 MANEA MAP3K1 AHNAK CARD6 MACF1 CNN3 MAP3K19	1.05e-03	352	153	9	GSM538198_500
CoexpressionAtlas	dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_1000	FOS ID2 MUC16 ZDBF2 BCL9 GLI3 NYNRIN MME PLEKHH2	1.09e-03	354	153	9	gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k3_1000
CoexpressionAtlas	FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5	SMARCA5 FANCM SLF2	1.17e-03	29	153	3	Facebase_RNAseq_e9.5_Mandibular Arch_500_K5
CoexpressionAtlas	dev gonad_e11.5_M_GonMes_Sma_top-relative-expression-ranked_1000	TICRR AFF2 FOS PEG3 ID2 MUC16 ZDBF2 BCL9 LRRC4 IGSF10 POM121 GLI3 MME PLEKHH2 CNN3	1.24e-03	849	153	15	gudmap_dev gonad_e11.5_M_GonMes_Sma_1000
CoexpressionAtlas	DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#3_top-relative-expression-ranked_1000	MAP4 KIF1B ANKRD26 MYSM1 CEP295 TOP1 SENP7	1.25e-03	225	153	7	gudmap_developingGonad_e14.5_ ovary_1000_k3
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_MedNas_2500	TICRR SMARCA5 AFF2 CENPC KIAA0586 ANKRD26 ZDBF2 BCL9 FANCM CWC25 EMSY HNRNPU CDCA2 ALMS1 PIK3CD GLI3 MACF1 CEP295 HSPA4 TOP1 TP53BP1	1.26e-03	1414	153	21	facebase_RNAseq_e10.5_Emin_MedNas_2500
CoexpressionAtlas	dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#2_top-relative-expression-ranked_500	COL6A3 MUC16 ZDBF2 NYNRIN EGFLAM MME	1.27e-03	165	153	6	gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k2_500
CoexpressionAtlas	alpha beta T cells, T.8Mem.Sp.OT1.d106.VSVOva, CD8+ CD45.1+, Spleen, avg-2	ID2 SRPK1 UST DENND4C NSG2 AHNAK CARD6 MACF1 SAMD3	1.40e-03	367	153	9	GSM538401_500
CoexpressionAtlas	DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#2_top-relative-expression-ranked_1000	MAP4 KIAA0586 MYSM1 MAP3K1 CEP295 TOP1 SENP7	1.42e-03	230	153	7	gudmap_developingGonad_e16.5_ovary_1000_k2
CoexpressionAtlas	dev gonad_e12.5_F_GermCellOvary_Oct_k-means-cluster#2_top-relative-expression-ranked_500	SYCP2 ALMS1 MAEL FGD6	1.48e-03	68	153	4	gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_k2_500
CoexpressionAtlas	dev gonad_e12.5_F_GermCellOvary_Oct_k-means-cluster#2_top-relative-expression-ranked_1000	SYCP2 ALMS1 SCAPER MAEL FGD6	1.48e-03	115	153	5	gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_k2_1000
CoexpressionAtlas	dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000	COL6A3 AFF2 VEZF1 PEG3 MUC16 GRIN2A BCL9 IGSF10 GLI3 NYNRIN LTN1 EGFLAM MME PLEKHH2	1.50e-03	777	153	14	gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000
CoexpressionAtlas	gamma delta T cells, Tgd.vg1+vd6-.Th, TCRd+ Vg1.1+, Thymus, avg-3	TICRR DLGAP5 TACC2 CDCA2 NSG2 MPP4 CCNB2 TACC3 CNN3	1.57e-03	373	153	9	GSM605781_500
CoexpressionAtlas	dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500	COL6A3 AFF2 PEG3 MUC16 GLI3 NYNRIN EGFLAM MME PLEKHH2	1.57e-03	373	153	9	gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_500
ToppCell	Non-neuronal-Dividing-Radial_Glia\|World / Primary Cells by Cluster	FOS GTSE1 DLGAP5 CENPQ CDCA2 CCNB2 GLI3 TACC3 CNN3	3.63e-08	200	155	9	ecbbad00e16041a9e1cd88d8bd7279a1b52c0aa4
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c12-MKI67-TYROBP\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	TICRR DLGAP5 LIN9 CENPQ CDCA2 SYCP2 CCNB2 SAMD3	1.65e-07	172	155	8	fe3d0d8cb5f613ac2cfff450599698f1533a354f
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TICRR GTSE1 DLGAP5 CDCA2 ALMS1 CCNB2 SAMD3 TACC3	2.44e-07	181	155	8	e4dbc09f0210de465d8347969b301c22463a2b7d
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1\|TCGA-Pancreas / Sample_Type by Project: Shred V9	MED1 NCOA4 LIN9 MAP3K1 ALMS1 LTN1 CEP295 ASXL2	3.01e-07	186	155	8	03db813598b67b1e08f759758a1c2023396921fa
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TICRR COL6A3 GTSE1 DLGAP5 LIN9 CDCA2 GLI3 TACC3	3.13e-07	187	155	8	e41e39fd3791acf8ae5376cc5061e196d96868ae
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TICRR COL6A3 GTSE1 DLGAP5 LIN9 CDCA2 GLI3 TACC3	3.13e-07	187	155	8	cefa211ef224e803ea9467882e2ca74d0b1492f1
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TICRR RIN3 GTSE1 DLGAP5 CENPQ CDCA2 PIK3CD TACC3	3.13e-07	187	155	8	73931a5ea73799095daff100b5f18853c57c74dc
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TICRR GTSE1 DLGAP5 CCDC168 CDCA2 CCNB2 SAMD3 TACC3	3.26e-07	188	155	8	319fbeca200ab998daf49fcaee0bfdb57bf7ee4b
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW19-Stem_cells-Stem_cells\|GW19 / Sample Type, Dataset, Time_group, and Cell type.	RIN3 GTSE1 DLGAP5 MANEA DDB2 CDCA2 CCNB2 TACC3	4.83e-07	198	155	8	50f236ab7ef6f00721f6cd714e3eee183077beeb
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW19-Stem_cells\|GW19 / Sample Type, Dataset, Time_group, and Cell type.	RIN3 GTSE1 DLGAP5 MANEA DDB2 CDCA2 CCNB2 TACC3	4.83e-07	198	155	8	dc0c6189ff9dd76675f63acf1cbc7dda60e75f3f
ToppCell	18-Airway-Mesenchymal-Mesenchyme_RSPO2+\|Airway / Age, Tissue, Lineage and Cell class	COL6A3 GTSE1 DLGAP5 CDCA2 CCNB2 MACF1 TACC3 PLEKHH2	5.02e-07	199	155	8	7ac35e8f45dcdc702422dabd8f3e4d03e2bf61af
ToppCell	Non-neuronal\|World / Primary Cells by Cluster	FOS GTSE1 DLGAP5 SLCO1C1 CCNB2 GLI3 TACC3 CNN3	5.02e-07	199	155	8	165d9de6cedc79e13bb6fa244e8898a5dacc54ff
ToppCell	NS-moderate-d_0-4-Epithelial\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ST6GALNAC1 MUC16 TACC2 MAGED2 NFE2L2 AHNAK CNN3 MUC20	5.21e-07	200	155	8	64462a18afca3c1a8548a857924b8166058bf958
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	GTSE1 DLGAP5 CDCA2 CCNB2 CEP295 TACC3 DNMT1	2.17e-06	169	155	7	b253a4a50c06d36228fcd5d856c57202cbac158f
ToppCell	PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_G2M\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TICRR DLGAP5 NCOA4 CENPQ CDCA2 CCNB2 TACC3	2.26e-06	170	155	7	e08a6c5ac34c456da8c7318f104e06fca585be1f
ToppCell	Dividing_Macrophages-IPF_03\|World / lung cells shred on cell class, cell subclass, sample id	GTSE1 DLGAP5 CCDC168 CDCA2 CCNB2 CEP295 TACC3	2.74e-06	175	155	7	0a8bf455babb3271aa00642199fb58b0b02dc3ac
ToppCell	PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_G2M\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CENPC DLGAP5 ID2 CDCA2 CCNB2 SAMD3 TACC3	2.74e-06	175	155	7	ae7e0448ffd11b8908d0f6d99ff737faf5eca4bf
ToppCell	PND01-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CENPC GTSE1 DLGAP5 CENPQ CDCA2 CCNB2 TACC3	2.84e-06	176	155	7	8385435074cc5235b7af7424974f609388fc2cff
ToppCell	Dividing_Macrophages-IPF_02\|World / lung cells shred on cell class, cell subclass, sample id	TICRR GTSE1 DLGAP5 CENPQ CDCA2 CCNB2 TACC3	3.06e-06	178	155	7	1893fadac2ec3d5de0a641e57b7b2f962012a9ba
ToppCell	Control-Developping_Plasmablast\|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5)	TICRR GTSE1 DLGAP5 MANEA CDCA2 SLC7A1 CCNB2	3.18e-06	179	155	7	9383568f78b07b8cca72ece5d15fea209aa54ea9
ToppCell	control-Lymphoid-NKT-proliferating\|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	SEMA3F TICRR GTSE1 DLGAP5 CDCA2 CCNB2 TACC3	3.30e-06	180	155	7	535535a67b3f3320bad2f98b1bc98a7b0ee77840
ToppCell	droplet-Thymus-nan-24m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TICRR GTSE1 DLGAP5 CDCA2 CCNB2 CEP295 TACC3	3.55e-06	182	155	7	39f9b3eb22293cc27c6e175702c77d1eeb24fdc9
ToppCell	droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CENPC GTSE1 DLGAP5 TACC2 CENPQ CDCA2 CCNB2	3.68e-06	183	155	7	e91f00b75d43ee6293fdd4a129b789cd95f8d11a
ToppCell	Dividing_Macrophages-IPF_01\|World / lung cells shred on cell class, cell subclass, sample id	TICRR GTSE1 DLGAP5 CENPQ CDCA2 CCNB2 TACC3	3.81e-06	184	155	7	f15ce786d25c6546804a6d1efcc2ad645f2ef54e
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating-T_cells_proliferating_L.1.1.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TICRR GTSE1 DLGAP5 CDCA2 CCNB2 TACC3 DNMT1	3.81e-06	184	155	7	8260e688ec42a1374727bc85dceb7edd19a8b662
ToppCell	Control-T_cells-Cycling_NK/T_cells\|Control / group, cell type (main and fine annotations)	TICRR AFF2 GTSE1 DLGAP5 LIN9 CDCA2 TACC3	3.95e-06	185	155	7	9766216b41ee62bbac4caa25cb98ec5627a24075
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Epithelial-neuronal_stem_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TICRR GTSE1 DLGAP5 CDCA2 GDPD4 CCNB2 TACC3	4.24e-06	187	155	7	a2076599b33ae6750961b573bfebcb9036fa4ee8
ToppCell	MatrixFB-Fibroblast-E_(Early_Fibroblastic_progenitor)\|MatrixFB / shred on cell class and cell subclass (v4)	GTSE1 DLGAP5 CENPQ CDCA2 CCNB2 TACC3 DNMT1	4.39e-06	188	155	7	b240ea20750ffb825cb5fe41d06c632233406ab6
ToppCell	COVID-19-Epithelial-Ionocytes\|COVID-19 / Condition, Lineage and Cell class	SEMA3F MUC16 TACC2 CLCNKA CLCNKB CNN3 MUC20	4.39e-06	188	155	7	a581cb9528d0febbf3addbb4f6bc140f91a584e6
ToppCell	NS-moderate-d_16-33-Epithelial-FOXN4+\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DLGAP5 RMI1 SYCP2 ASAP2 LRRIQ1 ALMS1 CEP295	4.71e-06	190	155	7	250ca4a605c1cccd77d23383e4fe6f91cf3609ba
ToppCell	pdx-Tumor_cells-T1\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	TICRR GTSE1 DLGAP5 LIN9 CDCA2 CEP295 TACC3	4.71e-06	190	155	7	d06ee5f89f1cec8db6897fe3b2a890a07cd3697b
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	TICRR GTSE1 KIAA0586 DLGAP5 CDCA2 CCNB2 TACC3	4.87e-06	191	155	7	0ba5b112a82e489f5a21966f78a403a7436ce73b
ToppCell	356C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating_2\|356C / Donor, Lineage, Cell class and subclass (all cells)	GTSE1 DLGAP5 CENPQ CDCA2 CCNB2 MME TACC3	4.87e-06	191	155	7	a2c235a55094e4fd5273d764c9e2967116b48c23
ToppCell	E17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	CENPC GTSE1 DLGAP5 CENPQ CDCA2 CCNB2 TACC3	4.87e-06	191	155	7	f764cc21fef87ebad765011098f647ae1bdf6158
ToppCell	droplet-Lung-30m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l12-14\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	IMPDH2 GTSE1 DLGAP5 CDCA2 CCNB2 TACC3 DNMT1	5.04e-06	192	155	7	52d0aa51e3b6ab3608a5f40bdde9f8134b3afd94
ToppCell	droplet-Thymus-nan-3m\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DLGAP5 MRPL58 HNRNPU NSG2 CCNB2 TACC3 TOP1	5.04e-06	192	155	7	d9e61b2722aa81e4f6e11865a04f2f1e75b794ab
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	TICRR GTSE1 KIAA0586 DLGAP5 CDCA2 CCNB2 TACC3	5.04e-06	192	155	7	026f3e38970bea1e6e8d76a4e2becdfb8484b2ff
ToppCell	Proliferating\|World / shred by cell class for mouse tongue	TICRR GTSE1 DLGAP5 CENPQ CDCA2 CCNB2 TACC3	5.04e-06	192	155	7	f081f3f957cc782294e118fcc1055f6a4264ee98
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	SMARCA5 KIF1B MED1 BCL9 DENND4C SBF2 ASXL2	5.22e-06	193	155	7	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	human_hepatoblastoma-Tumor_cells-T1\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	TICRR GTSE1 DLGAP5 FANCM CDCA2 CEP295 TACC3	5.22e-06	193	155	7	4b9fa2a4424f8abe63fa7bee78db93dda04ab15f
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TICRR GTSE1 DLGAP5 CDCA2 CCNB2 MME TACC3	5.22e-06	193	155	7	e45ce9cf8421512b57f157c24b64793b47b4ba4b
ToppCell	PSB-critical-LOC-Epithelial-FOXN4+\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DLGAP5 CDCA2 RMI1 ASAP2 CCNB2 CEP295 TACC3	5.22e-06	193	155	7	b7d9c5bed524423e92f01496a9f8fad11b33a3f7
ToppCell	PCW_13-14-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	TICRR GTSE1 DLGAP5 CDCA2 LRRIQ1 CCNB2 TACC3	5.40e-06	194	155	7	c197e4acbff42a9f0410b6801c2bfcf6160aefc1
ToppCell	wk_20-22-Hematologic_Lymphocytic-B-Pro-B\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	TICRR GTSE1 DLGAP5 SPANXB1 CDCA2 CCNB2 MME	5.40e-06	194	155	7	3590ff471f74a361ee5bf02a58e3104cd3bf7d00
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	COL6A3 TSHZ3 MAP3K1 GLI3 SBF2 MACF1 PLEKHH2	5.40e-06	194	155	7	b1bb0f846d2865efdd9bc8842b16b9d069785882
ToppCell	moderate-Epithelial-FOXN4+\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	DLGAP5 RMI1 SYCP2 ASAP2 LRRIQ1 ALMS1 CEP295	5.40e-06	194	155	7	5dffa578149104dda33774361e9e77b227b5f1ce
ToppCell	moderate-Epithelial-FOXN4+\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	DLGAP5 RMI1 SYCP2 ALMS1 CEP95 CEP295 DNMT1	5.40e-06	194	155	7	dff3fb10372053951d41e0ccd41aac3ece6009bd
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A3 IGSF10 MAMDC2 MACF1 MME PLEKHH2 MUSK	5.58e-06	195	155	7	df409f94f4e83be89f7a608058ee07ce3ce3a149
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A3 IGSF10 MAMDC2 MACF1 MME PLEKHH2 MUSK	5.58e-06	195	155	7	4243190ad291d56694e2155954dbaa879c9d3844
ToppCell	metastatic_Lymph_Node-B_lymphocytes-GC_B_cells_in_the_DZ\|metastatic_Lymph_Node / Location, Cell class and cell subclass	GTSE1 DLGAP5 CDCA2 CCNB2 MME TACC3 DNMT1	5.58e-06	195	155	7	3c5b7cce4a1c4b28fa3b657cce4148669a59e55e
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Proliferating-Cycling_Progenitors\|3.5_mon / Sample Type, Dataset, Time_group, and Cell type.	GTSE1 DLGAP5 CENPQ CDCA2 CCNB2 GLI3 TACC3	5.77e-06	196	155	7	5905f0e3061a6b98b7a33d64c782c3dda2cd51ef
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CENPC GTSE1 DLGAP5 CENPQ CDCA2 CCNB2 TACC3	5.77e-06	196	155	7	20383d576708b7e4bfce3e9fe40548cce496e3cb
ToppCell	COVID-19-lung-Proliferative_fibroblast\|lung / Disease (COVID-19 only), tissue and cell type	TICRR COL6A3 GTSE1 DLGAP5 CDCA2 CCNB2 TACC3	5.77e-06	196	155	7	2ce8a787f2731faa913d20342d73041d59468f27
ToppCell	COVID-19-lung-Proliferative_fibroblast\|COVID-19 / Disease (COVID-19 only), tissue and cell type	TICRR COL6A3 GTSE1 DLGAP5 CDCA2 CCNB2 TACC3	5.77e-06	196	155	7	ca91d5e325875e7444809b80fcbd491d8899ea36
ToppCell	distal-Hematologic-Proliferating_NK/T-2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	TICRR GTSE1 DLGAP5 CDCA2 CCNB2 SAMD3 TACC3	5.97e-06	197	155	7	04b10879e48c101d1de449db0bc6b6484090b965
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	COL6A3 IGSF10 GLI3 SBF2 MACF1 MME PLEKHH2	5.97e-06	197	155	7	0034bae02ee7fcfea520d453ca3c842ab6963b12
ToppCell	H1299-infected-SARSCoV2\|infected / Cell line, Condition and Strain	ANKRD26 SYCP2 TAF3 AHNAK SCAPER CEP295 DNMT1	5.97e-06	197	155	7	0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e
ToppCell	10x5'-GI_large-bowel-Lymphocytic_B-GC_B_(I)\|GI_large-bowel / Manually curated celltypes from each tissue	TICRR GTSE1 DLGAP5 CDCA2 CCNB2 FGD6 DNMT1	5.97e-06	197	155	7	80a0cfbd454409594effead7082586b06c2f411a
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	GTSE1 DLGAP5 ID2 CDCA2 CCNB2 SAMD3 TACC3	6.17e-06	198	155	7	4909a97c62702704a0327b9a2cd73f048c8afeb6
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Proliferating-cycling_dorsal_progenitors\|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.	CENPC GTSE1 KIAA0586 DLGAP5 CDCA2 CCNB2 TACC3	6.17e-06	198	155	7	5f0964c3aa7e1dc52cbb46e754078920b65bcb88
ToppCell	distal-2-Hematologic-Proliferating_NK/T\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	TICRR GTSE1 DLGAP5 CDCA2 CCNB2 SAMD3 TACC3	6.17e-06	198	155	7	a5fd710df5669c95fc5b5ef6e5cfafe6687c7b72
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Proliferating\|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.	CENPC GTSE1 KIAA0586 DLGAP5 CDCA2 CCNB2 TACC3	6.17e-06	198	155	7	629d674a9c9108c1acb3f7af57bbdbf34bb0528e
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SEMA3F TICRR GTSE1 DLGAP5 CDCA2 SERPINB5 TACC3	6.17e-06	198	155	7	f088badb90c6c2d916195f5649eda102119c9ac6
ToppCell	cycling_basal_cell\|World / shred by cell class for turbinate	TICRR GTSE1 DLGAP5 CDCA2 CCNB2 TACC3 DNMT1	6.17e-06	198	155	7	e86c1224f5b0890a50a25257628e90c790aae7cd
ToppCell	356C-Myeloid-Dendritic-cDC_proliferating_1\|356C / Donor, Lineage, Cell class and subclass (all cells)	TICRR GTSE1 DLGAP5 CDCA2 CCNB2 TACC3 DNMT1	6.17e-06	198	155	7	f801157468e59b5d049f703feadc9bb0f11e85cc
ToppCell	BAL-Mild-Epithelial-Epithelial\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ST6GALNAC1 MUC16 TACC2 LRRIQ1 CNN3 MAP3K19 MUC20	6.37e-06	199	155	7	1ee4010d8557564e25e8ee00b914c2dfd9037838
ToppCell	BAL-Mild-Epithelial-Epithelial\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	ST6GALNAC1 MUC16 TACC2 LRRIQ1 CNN3 MAP3K19 MUC20	6.37e-06	199	155	7	1df69c0cb5f759f6a2152521842506a75bb95cae
ToppCell	Leuk-UTI-Lymphocyte-T_NK-T_NK_proliferative\|Leuk-UTI / Disease, Lineage and Cell Type	TICRR GTSE1 DLGAP5 CDCA2 CCNB2 TACC3 DNMT1	6.37e-06	199	155	7	87113d398585076ece86b9098781e817f8ca241b
ToppCell	Mild-Epithelial-Epithelial-\|Mild / Condition, Lineage, Cell class and cell subclass	ST6GALNAC1 MUC16 TACC2 LRRIQ1 CNN3 MAP3K19 MUC20	6.37e-06	199	155	7	81115bbd2c10bfdd38376d2075f03a59c31870d2
ToppCell	suprabasal_cell\|World / shred by cell class for turbinate	IMPDH2 FOS NCOA4 SERPINB5 NFE2L2 AHNAK CNN3	6.37e-06	199	155	7	bfab5380ef074d14f0b5ed10851ad5c898eb9a58
ToppCell	(2)_B_cell-(24)_B_cell_cycling\|(2)_B_cell / shred on Cell_type and subtype	AFF2 GTSE1 DLGAP5 TACC2 CDCA2 CCNB2 TACC3	6.37e-06	199	155	7	d5a9a8a71c4de8cbcef947943f60838731bc640b
ToppCell	3'-GW_trimst-2-LargeIntestine-Mesenchymal\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IMPDH2 FOS PEG3 MAGED2 AHNAK EGFLAM CNN3	6.37e-06	199	155	7	c007cd51577e31553395ceaed70ad447e5854546
ToppCell	BAL-Mild-Epithelial\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ST6GALNAC1 MUC16 TACC2 LRRIQ1 CNN3 MAP3K19 MUC20	6.37e-06	199	155	7	74087b4b5e567310fc4ac58fb267ff651a180680
ToppCell	Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_alveolar-Macro_alv_dividing\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	GTSE1 DLGAP5 BCL9 CCNB2 MME TACC3 FGD6	6.37e-06	199	155	7	c6d59ed26eadd3c41acfe1b4d929270e00ea3e95
ToppCell	BAL-Mild-Epithelial\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	ST6GALNAC1 MUC16 TACC2 LRRIQ1 CNN3 MAP3K19 MUC20	6.37e-06	199	155	7	00b5ce099c50a5e1786ce2b3a06ee0931a8205a4
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL6A3 TSHZ3 MAGED2 NFE2L2 GLI3 PLEKHH2 MUSK	6.37e-06	199	155	7	da016849b804fbf80edbfa8f8f56c9df8bbf2d51
ToppCell	Mild-Epithelial\|Mild / Condition, Lineage, Cell class and cell subclass	ST6GALNAC1 MUC16 TACC2 LRRIQ1 CNN3 MAP3K19 MUC20	6.37e-06	199	155	7	ec5fff80e2a8a94fbaf1fdcc6d45c8d7c6252e18
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	ZNF609 DENND1A PACS1 TBC1D22A SBF2 SCAPER NCOA1	6.37e-06	199	155	7	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	Mild-Epithelial-Epithelial\|Mild / Condition, Lineage, Cell class and cell subclass	ST6GALNAC1 MUC16 TACC2 LRRIQ1 CNN3 MAP3K19 MUC20	6.37e-06	199	155	7	91308b255783ad4029e5575028c18d7550832c51
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-FOXM1\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	TICRR CENPC GTSE1 DLGAP5 CDCA2 CCNB2 TACC3	6.37e-06	199	155	7	98575fcce726589e93fbb4df1aab03e57cb56076
ToppCell	LPS_IL1RA-Endothelial-Endothelial-FOXM1\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	TICRR CENPC GTSE1 DLGAP5 CDCA2 CCNB2 TACC3	6.37e-06	199	155	7	be2276c9a1994579ba1d2998b49bf549c1324d44
ToppCell	Mild_COVID-19-Epithelial\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	ST6GALNAC1 MUC16 TACC2 LRRIQ1 CNN3 MAP3K19 MUC20	6.37e-06	199	155	7	72689bda7476930887ae007682fcab27f956f050
ToppCell	Transverse-B_cell-B_cell_cycling\|B_cell / Region, Cell class and subclass	AFF2 GTSE1 TACC2 LIN9 CENPQ TACC3 FGD6	6.37e-06	199	155	7	170ae68963d31f3b821b6f0e8f0c039bea0bc981
ToppCell	Non-neuronal-Dividing\|World / Primary Cells by Cluster	FOS GTSE1 DLGAP5 CDCA2 CCNB2 GLI3 TACC3	6.59e-06	200	155	7	50fa7b34a05f2c5ebbc7d113bd8e31326688a231
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-FOXM1\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	TICRR CENPC GTSE1 DLGAP5 CDCA2 CCNB2 TACC3	6.59e-06	200	155	7	4cfe08878a6981bf7b3567f9e82192d8f060ddde
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-3m-Stem_cells-Neuroepithelial_cell\|3m / Sample Type, Dataset, Time_group, and Cell type.	GTSE1 DLGAP5 CENPQ CDCA2 CCNB2 GLI3 TACC3	6.59e-06	200	155	7	2938a029fa0478be561574ace91f95c4a528b2d4
ToppCell	LPS_IL1RA-Epithelial_airway-airway_epithelial\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ST6GALNAC1 CCDC60 SERPINB5 LRRIQ1 TTLL6 MAP3K19 MUC20	6.59e-06	200	155	7	cf191104484bfb2b9f87de416b9453135f8833c1
ToppCell	Control_saline-Endothelial-Endothelial-FOXM1\|Control_saline / Treatment groups by lineage, cell group, cell type	TICRR CENPC GTSE1 DLGAP5 CDCA2 CCNB2 TACC3	6.59e-06	200	155	7	9bbc7b5561151f6ff65f40b3226271def732e5d9
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-3_mon-Radial_glial\|3_mon / Sample Type, Dataset, Time_group, and Cell type.	GTSE1 DLGAP5 NFE2L2 CCNB2 GLI3 TACC3 CNN3	6.59e-06	200	155	7	49197316231e45f8c9f007f55b036600f7195922
ToppCell	LPS_IL1RA-Epithelial_airway\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ST6GALNAC1 CCDC60 SERPINB5 LRRIQ1 TTLL6 MAP3K19 MUC20	6.59e-06	200	155	7	a5ae33dd4dc1ff6e1a1eec22c4d523d5ab657607
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-3m-Stem_cells\|3m / Sample Type, Dataset, Time_group, and Cell type.	GTSE1 DLGAP5 CENPQ CDCA2 CCNB2 GLI3 TACC3	6.59e-06	200	155	7	cfe017b4a4d604a553d0a3df9659687f38e9a7af
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-3_mon-Radial_glial-RG\|3_mon / Sample Type, Dataset, Time_group, and Cell type.	GTSE1 DLGAP5 NFE2L2 CCNB2 GLI3 TACC3 CNN3	6.59e-06	200	155	7	dea7928d6ceb7a347f56c6d0c9c7a56b7a2c0a80
ToppCell	critical-Epithelial-FOXN4+\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	DLGAP5 RMI1 ASAP2 CCNB2 CEP295 TACC3 DNMT1	6.59e-06	200	155	7	f39db4250ce220a3eb58edee3f7fc3671701d46f
ToppCell	Non-neuronal-Dividing-Radial_Glia-vRG\|World / Primary Cells by Cluster	FOS GTSE1 DLGAP5 CENPQ CDCA2 CCNB2 TACC3	6.59e-06	200	155	7	7596143925cd403ec7baceef87d19d570e48586a
ToppCell	Biopsy_IPF-Immune-Proliferating_T_cells\|Biopsy_IPF / Sample group, Lineage and Cell type	TICRR GTSE1 DLGAP5 CDCA2 CCNB2 SAMD3 TACC3	6.59e-06	200	155	7	c43d1a83b2a8ad060f3d80c9438da8b7a5e307fb
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW12-Stem_cells\|GW12 / Sample Type, Dataset, Time_group, and Cell type.	TICRR CENPC GTSE1 DLGAP5 CCNB2 GLI3 TACC3	6.59e-06	200	155	7	0bba93f1271dac704dddcdea8cb0f84a7ac6f42a
ToppCell	Sepsis-Leuk-UTI-Lymphocyte-T/NK-T/NK_proliferative\|Leuk-UTI / Disease, condition lineage and cell class	TICRR GTSE1 DLGAP5 CDCA2 CCNB2 TACC3 DNMT1	6.59e-06	200	155	7	093e97395be23092229521cc55aaaee8befbc149
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW12-Stem_cells-Neuroepithelial_cell\|GW12 / Sample Type, Dataset, Time_group, and Cell type.	TICRR CENPC GTSE1 DLGAP5 CCNB2 GLI3 TACC3	6.59e-06	200	155	7	c9479452ab8c51139522383f745f02171ebbd7e2
ToppCell	PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TICRR DLGAP5 CDCA2 CCNB2 PIK3CD TACC3	1.06e-05	142	155	6	be63c48794a227ea55978524c0f5935342fc455e
ToppCell	E16.5-samps\|World / Age Group, Lineage, Cell class and subclass	IMPDH2 CDCA2 MAGED2 CCNB2 TACC3 DNMT1	1.39e-05	149	155	6	e94d075f68c1c70c89fab50b1b765b5dda650d09
Drug	Thapsigargin	TICRR COL6A3 CEBPG MAP4 FOS PEG3 DLGAP5 ID2 UTP23 PPEF1 MYSM1 DENND4C CDCA2 RMI1 SLC7A1 PER2 NFE2L2 AHNAK DHCR7 LTN1 MACF1 HERPUD1 CNN3 TP53BP2 SENP7 DNMT1	1.50e-06	1353	155	26	ctd:D019284
Disease	Charcot-Marie-Tooth disease	KIF1B JPH1 SGPL1 SBF2 MME	2.64e-06	42	154	5	cv:C0007959
Disease	Bartter syndrome	CLCNKA CLCNKB MAGED2	2.76e-06	6	154	3	cv:C0004775
Disease	Bartter disease type 4B	CLCNKA CLCNKB	2.71e-05	2	154	2	cv:C4310805
Disease	Bartter disease type 3 (implicated_via_orthology)	CLCNKA CLCNKB	2.71e-05	2	154	2	DOID:0110144 (implicated_via_orthology)
Disease	BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	CLCNKA CLCNKB	2.71e-05	2	154	2	613090
Disease	BARTTER SYNDROME, TYPE 4B	CLCNKA CLCNKB	2.71e-05	2	154	2	C2751312
Disease	BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	CLCNKA CLCNKB	2.71e-05	2	154	2	C4310805
Disease	Bartter disease type 4b (is_implicated_in)	CLCNKA CLCNKB	2.71e-05	2	154	2	DOID:0110146 (is_implicated_in)
Disease	Bartter disease (implicated_via_orthology)	CLCNKA CLCNKB	2.71e-05	2	154	2	DOID:445 (implicated_via_orthology)
Disease	Liver carcinoma	TICRR FOS FLVCR1 GTSE1 DLGAP5 MED1 DIRAS3 CDCA2 NFE2L2 CCNB2 TACC3	7.65e-05	507	154	11	C2239176
Disease	Charcot-Marie-Tooth disease type 2	KIF1B JPH1 MME	8.98e-05	17	154	3	cv:C0270914
Disease	Withdrawal Symptoms	FOS GRIN2A PER2 HRH1	2.43e-04	58	154	4	C0087169
Disease	Drug Withdrawal Symptoms	FOS GRIN2A PER2 HRH1	2.43e-04	58	154	4	C0086189
Disease	Substance Withdrawal Syndrome	FOS GRIN2A PER2 HRH1	2.43e-04	58	154	4	C0038587
Disease	alkaline phosphatase measurement	RIN3 MAP4 POM121 SLF2 GLI3 NYNRIN AHNAK MACF1 PLEKHH2 HSPA4 MUSK ALPK2 TP53BP1 SENP7 DNMT1	2.89e-04	1015	154	15	EFO_0004533
Disease	breast cancer, lung cancer	RIN3 MAP3K1 HSPA4	2.95e-04	25	154	3	MONDO_0007254, MONDO_0008903
Disease	level of Phosphatidylcholine (O-18:2_18:2) in blood serum	HERPUD1 MUSK	4.00e-04	6	154	2	OBA_2045134
Disease	level of Phosphatidylcholine (O-16:0_18:2) in blood serum	HERPUD1 MUSK	4.00e-04	6	154	2	OBA_2045114
Disease	neuroimaging measurement	KIF1B TACC2 DENND1A DENND4C MAP3K1 EFTUD2 JPH1 LRRIQ1 GLI3 CNKSR3 MACF1 MAEL TACC3 FGD6 MUSK	4.97e-04	1069	154	15	EFO_0004346
Disease	Malignant neoplasm of breast	FOS MANEA TACC2 EMSY MAP3K1 SERPINB5 PER2 MAGED2 NCOA1 MACF1 MME TOP1 TP53BP1 TP53BP2 DNMT1	5.22e-04	1074	154	15	C0006142
Disease	esterified cholesterol measurement	ASAP2 NYNRIN HERPUD1 TOP1 MUSK	5.73e-04	128	154	5	EFO_0008589
Disease	migraine disorder, endometriosis	ASCC1 CDCA2 SBF2 FGD6	5.87e-04	73	154	4	EFO_0001065, MONDO_0005277
Disease	cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement	DDB2 RMI1 SBF2 MACF1 HERPUD1 MUSK TP53BP1	6.41e-04	276	154	7	EFO_0004612, EFO_0020943
Disease	1-palmitoyl-2-linoleoyl-GPC (16:0/18:2) measurement	HERPUD1 MUSK	7.42e-04	8	154	2	EFO_0800610
Disease	1-palmitoyl-2-stearoyl-GPC (16:0/18:0) measurement	HERPUD1 MUSK	7.42e-04	8	154	2	EFO_0800396
Disease	1-(1-enyl-palmitoyl)-2-arachidonoyl-GPC (P-16:0/20:4) measurement	HERPUD1 MUSK	7.42e-04	8	154	2	EFO_0800423
Disease	Pena-Shokeir syndrome type I	ASCC1 MUSK	7.42e-04	8	154	2	C1276035
Disease	level of Phosphatidylcholine (18:0_20:5) in blood serum	AHNAK MUSK	9.51e-04	9	154	2	OBA_2045095
Disease	rheumatoid arthritis, Crohn's disease	EMSY C1orf141 MUSK	1.03e-03	38	154	3	EFO_0000384, EFO_0000685
Disease	nephrogenic diabetes insipidus (implicated_via_orthology)	CLCNKA CLCNKB	1.18e-03	10	154	2	DOID:12387 (implicated_via_orthology)
Disease	level of Phosphatidylcholine (O-18:2_16:0) in blood serum	HERPUD1 MUSK	1.18e-03	10	154	2	OBA_2045132
Disease	aortic stenosis, aortic valve calcification	FBRSL1 MYSM1 DENND4C	1.38e-03	42	154	3	EFO_0000266, EFO_0005239
Disease	Prostatic Neoplasms	ABR MAP3K1 SLC7A1 NFE2L2 PIK3CD NCOA1 MME HERPUD1 CNN3 DNMT1	1.53e-03	616	154	10	C0033578
Disease	Malignant neoplasm of prostate	ABR MAP3K1 SLC7A1 NFE2L2 PIK3CD NCOA1 MME HERPUD1 CNN3 DNMT1	1.53e-03	616	154	10	C0376358
Disease	C-reactive protein measurement	SEMA3F CCDC60 CCDC168 GTPBP1 DDB2 MAP3K1 PACS1 NFE2L2 NYNRIN AHNAK MACF1 HERPUD1 TOP1 MUSK TP53BP1	1.67e-03	1206	154	15	EFO_0004458
Disease	metabolite measurement, body weight gain	TACC2 MUSK	1.73e-03	12	154	2	EFO_0004566, EFO_0004725
Disease	Myoinositol measurement	FBRSL1 TBC1D22A	1.73e-03	12	154	2	EFO_0021652
Disease	1-(1-enyl-palmitoyl)-2-palmitoyl-GPC (P-16:0/16:0) measurement	HERPUD1 MUSK	1.73e-03	12	154	2	EFO_0800466
Disease	cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement	DDB2 RMI1 MACF1 HERPUD1 MUSK TP53BP1	1.79e-03	243	154	6	EFO_0004612, EFO_0020944
Disease	Mammary Carcinoma, Human	FOS EMSY MAP3K1 SERPINB5 NCOA1 MME TP53BP1 TP53BP2 DNMT1	1.82e-03	525	154	9	C4704874
Disease	Mammary Neoplasms, Human	FOS EMSY MAP3K1 SERPINB5 NCOA1 MME TP53BP1 TP53BP2 DNMT1	1.82e-03	525	154	9	C1257931
Disease	triglyceride measurement, alcohol drinking	HSPA4 HERPUD1 MUSK TP53BP1	1.83e-03	99	154	4	EFO_0004329, EFO_0004530
Disease	Mammary Neoplasms	FOS EMSY MAP3K1 SERPINB5 NCOA1 MME TP53BP1 TP53BP2 DNMT1	1.86e-03	527	154	9	C1458155
Disease	triglyceride measurement, alcohol consumption measurement	HSPA4 HERPUD1 MUSK TP53BP1	1.97e-03	101	154	4	EFO_0004530, EFO_0007878
Disease	fatty acid measurement, fetal genotype effect measurement, breast milk measurement	FAM135B MUSK	2.03e-03	13	154	2	EFO_0005110, EFO_0007959, EFO_0009092
Disease	level of Sphingomyelin (d34:2) in blood serum	SGPL1 MUSK	2.03e-03	13	154	2	OBA_2045174
Disease	level of Phosphatidylcholine (16:0_18:3) in blood serum	HERPUD1 MUSK	2.03e-03	13	154	2	OBA_2045072
Disease	Breast Carcinoma	FOS EMSY MAP3K1 SERPINB5 NCOA1 MME TP53BP1 TP53BP2 DNMT1	2.14e-03	538	154	9	C0678222
Disease	alcohol consumption measurement	SEMA3F PCLO FBRSL1 MED1 DENND1A FAM135B ALMS1 TTLL6 NFE2L2 GLI3 CNKSR3 TTC12 SCAPER ASXL2 SENP7	2.21e-03	1242	154	15	EFO_0007878
Disease	wet macular degeneration	FGD6 HERPUD1	2.36e-03	14	154	2	EFO_0004683
Disease	level of Phosphatidylcholine (18:1_18:2) in blood serum	HERPUD1 MUSK	2.36e-03	14	154	2	OBA_2045100
Disease	fatty acid measurement, breast milk measurement, parental genotype effect measurement	FAM135B MUSK	2.36e-03	14	154	2	EFO_0005110, EFO_0005939, EFO_0009092
Disease	response to 5-fluorouracil, response to cyclophosphamide, chemotherapy-induced alopecia, response to doxorubicin	BCL9 DENND1A	2.36e-03	14	154	2	EFO_0005400, GO_0036275, GO_1902518, GO_1902520
Disease	diglyceride measurement	ABR HERPUD1 MUSK	2.42e-03	51	154	3	EFO_0010223
Disease	congestive heart failure (biomarker_via_orthology)	FOS NFE2L2 MME DNMT1	2.43e-03	107	154	4	DOID:6000 (biomarker_via_orthology)
Disease	level of Phosphatidylcholine (O-18:1_20:4) in blood serum	HERPUD1 MUSK	2.72e-03	15	154	2	OBA_2045131
Disease	level of Phosphatidylcholine (16:0_16:0) in blood serum	HERPUD1 MUSK	2.72e-03	15	154	2	OBA_2045067
Disease	high density lipoprotein cholesterol measurement, metabolic syndrome	HERPUD1 MUSK	2.72e-03	15	154	2	EFO_0000195, EFO_0004612
Disease	breast carcinoma	RIN3 MAP4 PPRC1 KIF1B ANKRD26 TACC2 MAP3K1 SLC7A1 MPP4 SBF2 NCOA1 ASXL2 HSPA4	2.73e-03	1019	154	13	EFO_0000305
Disease	Schizoaffective disorder-bipolar type	PCLO UTP23	3.10e-03	16	154	2	EFO_0009965
Disease	response to acetylsalicylate	MAP4 CNKSR3	3.10e-03	16	154	2	GO_1903492
Disease	level of Phosphatidylcholine (18:0_18:2) in blood serum	HERPUD1 MUSK	3.10e-03	16	154	2	OBA_2045090
Disease	cholesteryl esters to total lipids in medium HDL percentage	HERPUD1 MUSK TP53BP1	3.16e-03	56	154	3	EFO_0022251
Disease	response to efavirenz, virologic response measurement	MANEA CDCA2 IGSF10	3.49e-03	58	154	3	EFO_0006904, EFO_0006906
Disease	Bipolar Disorder	SLC12A6 PCLO GRIN2A BCL9 PACS1 PER2 HSPA4 DNMT1	3.69e-03	477	154	8	C0005586
Disease	sleep duration, high density lipoprotein cholesterol measurement	DDB2 MACF1 HERPUD1 MUSK	3.78e-03	121	154	4	EFO_0004612, EFO_0005271
Disease	migraine disorder, type 2 diabetes mellitus	DENND1A RMI1 GLI3	3.84e-03	60	154	3	MONDO_0005148, MONDO_0005277
Disease	cholesterol to total lipids in medium HDL percentage	DDB2 HERPUD1 TP53BP1	3.84e-03	60	154	3	EFO_0022237
Disease	Bone marrow hypocellularity	FANCM MYSM1	3.92e-03	18	154	2	C1855710
Disease	level of Phosphatidylcholine (15:0_18:2) in blood serum	HERPUD1 MUSK	3.92e-03	18	154	2	OBA_2045065
Disease	free cholesterol in very large VLDL measurement	HERPUD1 MUSK TP53BP1	4.02e-03	61	154	3	EFO_0022274
Disease	chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	DDB2 HERPUD1 TP53BP1	4.02e-03	61	154	3	EFO_0008317, EFO_0008596, EFO_0020946
Disease	total lipids in very large VLDL measurement	HERPUD1 MUSK TP53BP1	4.21e-03	62	154	3	EFO_0022313
Disease	lysophosphatidylcholine measurement	COL6A3 HERPUD1 MUSK	4.21e-03	62	154	3	EFO_0010224
Disease	phospholipids in very large VLDL measurement	HERPUD1 MUSK TP53BP1	4.21e-03	62	154	3	EFO_0022299
Disease	sodium-coupled monocarboxylate transporter 1 measurement	HERPUD1 MUSK	4.37e-03	19	154	2	EFO_0802076
Disease	cortical surface area measurement	TICRR RIN3 ABR KIF1B DENND1A MAP3K1 LRRIQ1 TBC1D22A PIK3CD GLI3 CNKSR3 MACF1 MAEL TACC3 FGD6	4.64e-03	1345	154	15	EFO_0010736
Disease	peak expiratory flow	TSHZ3 KIF1B UST PACS1 ASAP2 CNKSR3 SCAPER NCOA1	4.76e-03	498	154	8	EFO_0009718
Disease	cholesterol in very large VLDL measurement	HERPUD1 MUSK TP53BP1	4.81e-03	65	154	3	EFO_0022230
Disease	renal system measurement	SCAF8 MICALL2	4.83e-03	20	154	2	EFO_0004742
Disease	level of Phosphatidylcholine (16:0_18:2) in blood serum	HERPUD1 MUSK	4.83e-03	20	154	2	OBA_2045071

Protein segments in the cluster

Peptide	Gene	Start	Entry
PMKPLKATATTSQPV	ABR	116	Q12979
FPSPEMRKKTVITLN	BHLHB9	376	Q6PI77
MRKKTVITLNPPSGD	BHLHB9	381	Q6PI77
KSTVIKTEPPKVMET	C2orf16	686	Q68DN1
VPLQPSKQMKVTVSK	FBRSL1	156	Q9HCM7
SSVTSPIKMKIPIAN	CCNT2	476	O60583
LVESKKMSISNPKTI	EGFLAM	291	Q63HQ2
QSISLFKPQKTMPTV	C1orf141	261	Q5JVX7
VPPKKMEDLTNVSSL	CENPQ	126	Q7L2Z9
QKKMANSSPVLSKVP	CWC25	211	Q9NXE8
KTVMNSKTHPPKCIQ	DNMT1	341	P26358
SPPLETMTAQKILKT	ADGRG4	291	Q8IZF6
QTNSMTIKKAGPETP	ALPK2	2151	Q86TB3
KNIAMTGQITSTKPK	AFF2	941	P51816
PQQIKMQSTKKGPLT	GTPBP1	586	O00178
PEMKNLPDTKAITQK	ALMS1	3421	Q8TCU4
SSPKVSMPDVELNLK	AHNAK	3411	Q09666
SMPDVELNLKSPKVK	AHNAK	3416	Q09666
KIEMETKTSISIPKP	ASCC1	111	Q8N9N2
KNVPKPSLAKLMTAS	ANKRD26	271	Q9UPS8
LKPTIEMKDSVPNKA	ANKRD26	496	Q9UPS8
PQPKMKSSRQKSKTE	HSD11B1L	266	Q7Z5J1
MAAKSQPNIPKAKSL	DHCR7	1	Q9UBM7
QQLSTVVPSMGTKPK	TP53BP2	531	Q13625
VKKTPAEQPKSMPVS	ASXL2	401	Q76L83
PLTKVEMKTVPLTAK	ASXL2	971	Q76L83
MTKVPATKKLQSSPN	CCDC60	1	Q8IWA6
PSKMPEINAKVAEST	HERPUD1	91	Q15011
QAEITFKKPMPTKVV	MAMDC2	456	Q7Z304
IPQLMKEEASKVSPS	LTN1	286	O94822
LKIMSSKEPSISPEI	MUC16	3206	Q8WXI7
QVKTVKAEKPMTSQP	GLI3	691	P10071
VPQKFTATMSTPDKK	LIN9	86	Q5TKA1
KQNVSPPDMSALSLK	MAEL	91	Q96JY0
ADPQAVTMPATETKK	MAGED2	111	Q9UNF1
PTKLDVTLAKDMQPS	MAP4	281	P27816
MDQPPQAKKAKVKTS	HSPA4	561	P34932
PSVEPVKSISSMELK	FOS	251	P01100
AKITTSAKTTMKPPT	MUC20	626	Q8N307
PIASITKEKKITMQN	SBF2	946	Q86WG5
LSKPVPATKLNTMSK	KIF1B	1226	O60333
AKTPSVMEALSQPSK	ASAP2	851	O43150
TKKITLKTPLVSSPM	IMPDH2	56	P12268
SSVKIQVQPMVDPKT	KIAA2026	1081	Q5HYC2
PPKTMTSNLEKSSQE	KIAA1109	4601	Q2LD37
SQFSLPVQKKVMSTP	FANCM	1326	Q8IYD8
PVQKKVMSTPLSKSN	FANCM	1331	Q8IYD8
VTAIVNKPLMSKAPT	JPH1	506	Q9HDC5
PEAPMAKGKSTTLTQ	MICALL2	556	Q8IY33
QKKKSVTEMQTNPPA	PER2	536	O15055
QPKMVKPTTDLVSSS	PCLO	756	Q9Y6V0
PPMVTTDQKQEESKL	PCLO	1186	Q9Y6V0
KLVETTMVPSPEAKL	NFE2L2	206	Q16236
MVKLNSNPSEKGTKP	NSG2	1	Q9Y328
MSSSPVNVKKLKVSE	HNRNPU	1	Q00839
SQMDITDINTPKPKK	MME	6	P08473
PDKKDMKLSTATNPQ	MPP4	11	Q96JB8
NKPSKIPTMSKKTTT	MACF1	3491	O94854
PKQVAVPATDTTDKM	LRRC4	501	Q9HBW1
SDPVMSMQKTQKPQT	LCA10	146	Q71F78
FQTTLPTLKVDKPTM	GDPD4	601	Q6W3E5
KPQVSISITEKVKSM	AP5M1	206	Q9H0R1
MAPKKRPETQKTSEI	DDB2	1	Q92466
CLNSKTKVMPTPTNQ	GTSE1	436	Q9NYZ3
TKVMPTPTNQFKIPK	GTSE1	441	Q9NYZ3
PSKPKVMAESTIQSF	PEG3	796	Q9GZU2
RSPPQVVKSEEMSKI	PLEKHH2	201	Q8IVE3
ENKVSLPKSPKMVQP	LRRIQ1	1586	Q96JM4
TNTKNLKSVEITMKP	MANEA	71	Q5SRI9
TSLVVPEKVKTPMKS	PACS1	471	Q6VY07
PSTNPLLESLKKMQT	POM121B	176	A6NF01
EVIEQTKAPKAMTPS	NCOA4	466	Q13772
APSTNPLLESLKKMQ	POM121	591	Q96HA1
APTSIPMEKTHKVNA	IGSF10	1146	Q6WRI0
PMPALTTVKSQNSKL	IGSF10	1551	Q6WRI0
EILTPPNMTAKCNKT	IL3RA	206	P26951
KSSSKSQALMPIQEP	CARD6	691	Q9BX69
QLKPTASVKPVQMEK	CCNB2	71	O95067
NMLPSSTEVSVKTKK	CENPC	191	Q03188
TQKDKMSSPPSSPQK	FNDC3A	196	Q9Y2H6
KPKAKVPLQTLHMTS	DHX57	91	Q6P158
TQSSPKSKQEVMVRP	BCL9	16	O00512
KPVAAKPVATKMATV	COL6A3	2916	P12111
DMITEASQTPKEPTK	MRPL58	156	Q14197
VPEKTNVKPRAMKTI	DLGAP5	71	Q15398
SPPLMAKRTKQEIKT	DENND4C	741	Q5VZ89
KPNKAVPMKVSEHSL	CEP95	551	Q96GE4
IQPSFKMLKNTKPMT	C17orf80	116	Q9BSJ5
SPTDQEPKTVMLSKQ	FLVCR1	536	Q9Y5Y0
SPIKETVSSRQKPQM	CDCA2	936	Q69YH5
LNTVKTKANPAMKTV	DENND1A	416	Q8TEH3
NPKVEQEVSSSPKSM	KIAA1210	956	Q9ULL0
KITTIPMTSKPNVIV	EMSY	566	Q7Z589
PMTSKPNVIVVQKTT	EMSY	571	Q7Z589
SVLKSPSQTPKEMKS	HRH1	271	P35367
EEAISKPMQKLVSSP	CCDC168	691	Q8NDH2
VPVTSPTIMNLKDKE	FAM135B	431	Q49AJ0
DVPLVMKTQQIPSKV	CEP295	371	Q9C0D2
KPTTGLQEPEKKSQM	DIRAS3	201	O95661
SKTKEINNMTVPSKL	SLC12A6	391	Q9UHW9
DYKPPISKAKMTQIT	SCAF8	16	Q9UPN6
MPPSEVKLQSGKISR	SCNM1	146	Q9BWG6
ATPKIPTQEMKNKPS	SCAPER	1076	Q9BY12
PKHKVSALVQSPQMK	PPRC1	1066	Q5VV67
VAPSKQSKKSSPMDR	CEBPG	46	P53567
KPTMHKTSIKTQIFP	MAP3K19	561	Q56UN5
TVEDMVKKNLPPASS	MED1	531	Q15648
PEAKIPAKISQMTNL	LRRC8D	501	Q7L1W4
APTKPTAQLMATAQK	NYNRIN	591	Q9P2P1
TPKTPQAQKMPVAKT	NYNRIN	621	Q9P2P1
QFSSPSVKKKPSMIL	RIN3	561	Q8TB24
ERNKMKSVLIPPTET	PPEF1	301	O14829
TTVPKMLQIIFSPTK	OR1Q1	76	Q15612
TTTTEQPKPMVQTKG	MAP3K1	946	Q13233
IPVLTKKMNPRSTEA	MT-ND2	41	P03891
TSPIQSKSPTLKDMN	GAS2	281	O43903
QKTKSPKTAQSPAMV	TAF3	281	Q5VWG9
IQNTMVLDKPSPKTI	UTP23	141	Q9BRU9
PVTSKSSPERQLKVM	SENP7	86	Q9BQF6
QPAPKKMKTSESSTI	SPANXA1	36	Q9NS26
PKNLAKAMKVTFQTP	TACC3	46	Q9Y6A5
DPAPVKTMTISSKRQ	SEMA3F	516	Q13275
KSTTPQSPMEGKNKL	TMEM132B	846	Q14DG7
SVPTKGLSSDNKPMV	SARNP	131	P82979
FSVPEMKQSKKDPLQ	RMI1	556	Q9H9A7
KSPENPKKAALVMQT	SAMD3	71	Q8N6K7
MTKPTPEEIKLEAQS	NCOA1	791	Q15788
KKAAPTEVLSMTAQP	PIP5K1C	36	O60331
PSIPQNKKVSKMEIL	ID2	51	Q02363
SPEKEKTMVNTLSPR	ST6GALNAC1	126	Q9NSC7
ITVPSKTQTMSPHIK	SLC35B3	46	Q9H1N7
PSTMANAKVKLSIPK	SERPINB5	261	P36952
NKAKVTTMTPASNPI	RNF169	311	Q8NCN4
TKETKMQKPHLPLSQ	SLF2	431	Q8IX21
PPNKMTQEKLEESST	SRPK1	321	Q96SB4
ESVTQIMKNPKAKTT	SGPL1	506	O95470
QKMESFSAVPPTKEK	ANKHD1	2016	Q8IWZ3
VEMKKAISNLTNPPA	CLCNKA	671	P51800
VEMKKAISNLTNPPA	CLCNKB	671	P51801
ETNILPTKMREKTPS	CNK3/IPCEF1	411	G9CGD6
ETNILPTKMREKTPS	CNKSR3	411	Q6P9H4
PKMQTDKPFDQTTIS	CNN3	191	Q15417
KLGNMTVTVKKTVPS	UST	316	Q9Y2C2
KSTEQRKSMAPEPTQ	UHRF1BP1L	266	A0JNW5
ERLQKSPAKMTPTKQ	TICRR	1136	Q7Z2Z1
SPAKMTPTKQAAFKE	TICRR	1141	Q7Z2Z1
QSTQRKIKEGKMSPP	ZXDC	741	Q2QGD7
AMPVTQSVKKPSKPV	VEZF1	156	Q14119
SSVETPQISPAMAKK	SAGE2P	516	A6NJ88
SLKTILSPKNMEPSK	SLC7A1	476	P30825
KPPLQMTSSAEKPSV	SYCP2	511	Q9BX26
KGQPSSKMTPSKNIT	SYCP2	986	Q9BX26
QLPVSVMEKSKSKIS	SLCO1C1	161	Q9NYB5
IVISSVPQSTKKMKP	FGD6	36	Q6ZV73
KSEKMESPVSTPAVL	ZNF609	246	O15014
KSPSKLAVNPNKTDM	ZDBF2	301	Q9HCK1
LSSQKTPKPQTKELM	PIK3CD	701	O00329
SSTSKMQESPKLPQQ	TACC2	2351	O95359
VKDPVSPASQKMVIQ	TP53BP1	1096	Q12888
QQTPPHLTQKKMLKS	TTLL6	681	Q8N841
QTKLLEMQPTKAPEK	SNX19	771	Q92543
AKMPTTPVKAKRVST	TBC1D22A	46	Q8WUA7
NSAMKKGKPIVETPV	TSHZ3	416	Q63HK5
LKRNPMNVSSVVKPS	ZNF844	471	Q08AG5
LNKTMISPPQTAMKS	TTC12	61	Q9H892
PQPAPKKMKTSESST	SPANXB1	41	Q9NS25
KSAEMPTISKTVNPT	SPZ1	6	Q9BXG8
PVKTKKFTLMEQTLP	EFTUD2	96	Q15029
IQPAAQKTPTSPLKM	SMARCA5	106	O60264
KMQSIFPTIPKNSES	TMEM242	116	Q9NWH2
TTPPVMEQPVTKKVK	WDR87	1206	Q6ZQQ6
PPKTFEKSMMNLQTK	TOP1	636	P11387
MKSEKKDPPQLTVQV	KIAA0586	786	Q9BVV6
DSPQPVTMEKVVKQS	ZNF302	171	Q9NR11
PQMVKISKLPSDFTV	NALCN	641	Q8IZF0
NKENLKTFPPMTSSK	MUSK	456	O15146
QKTAKIMVHSPTKPA	MYSM1	101	Q5VVJ2
SVPVQNPKGTTSKIM	GRIN2A	616	Q12879